Previous Article | Next Article 
Microbiology and Molecular Biology Reviews, September 2006, p. 755-788, Vol. 70, No. 3
1092-2172/06/$08.00+0 doi:10.1128/MMBR.00008-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Mapping the Pathways to Staphylococcal Pathogenesis by Comparative Secretomics
M. J. J. B. Sibbald,1
A. K. Ziebandt,2
S. Engelmann,2
M. Hecker,2
A. de Jong,3
H. J. M. Harmsen,1
G. C. Raangs,1
I. Stokroos,4
J. P. Arends,1
J. Y. F. Dubois,1 and
J. M. van Dijl1*
Department
of Medical Microbiology, University Medical Centre Groningen and
University of Groningen, Hanzeplein
1, P.O. Box 30001, 9700 RB
Groningen, The Netherlands,1
Institut für
Mikrobiologie, Ernst-Moritz-Arndt Universität,
Greifswald, F.-L.-Jahnstr. 15, D-17487
Greifswald, Germany,2
Department of Genetics,
Groningen Biomolecular Sciences
and Biotechnology Institute, Kerklaan 30,
9751 NN Haren, The Netherlands,3
Department
of Cell Biology and Electron Microscopy,
University Medical Centre Groningen and University
of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The
Netherlands4

SUMMARY
The gram-positive bacterium
Staphylococcus aureus is a
frequent
component of the human microbial flora that can turn into a
dangerous
pathogen. As such, this organism is capable of infecting
almost
every tissue and organ system in the human body. It does so
by
actively exporting a variety of virulence factors to the
cell surface
and extracellular milieu. Upon reaching their respective
destinations,
these virulence factors have pivotal roles in
the colonization and
subversion of the human host. It is therefore
of major importance to
obtain a clear understanding of the protein
transport pathways that are
active in
S. aureus. The present
review aims to provide a
state-of-the-art roadmap of staphylococcal
secretomes, which include
both protein transport pathways and
the extracytoplasmic proteins of
these organisms. Specifically,
an overview is presented of the exported
virulence factors,
pathways for protein transport, signals for cellular
protein
retention or secretion, and the exoproteomes of different
S. aureus isolates. The focus is on
S. aureus, but
comparisons
with
Staphylococcus epidermidis and other
gram-positive bacteria,
such as
Bacillus subtilis, are
included where appropriate. Importantly,
the results of genomic and
proteomic studies on
S. aureus secretomes
are integrated
through a comparative "secretomics" approach,
resulting
in the first definition of the core and variant secretomes
of this
bacterium. While the core secretome seems to be largely
employed for
general housekeeping functions which are necessary
to thrive in
particular niches provided by the human host, the
variant secretome
seems to contain the "gadgets" that
S. aureus
needs
to conquer these well-protected
niches.

INTRODUCTION
The gram-positive
bacterium
Staphylococcus aureus is a frequent
component
of the human microbial flora that can turn into a dangerous
pathogen.
As such, this organism is capable of infecting almost every
tissue
and organ system in the human body. It does so by exporting
a
variety of virulence factors to the cell surface and extracellular
milieu
of the human host. Like all living organisms
(
201),
S.
aureus contains several protein transport pathways, among which
the
general secretory (Sec) pathway is the most well known and best
described.
Proteins that need to be transported to an extracytoplasmic
location
generally contain an N-terminal signal peptide that is needed
to
target the newly synthesized protein from the ribosome to
the
translocation machinery in the cytoplasmic membrane. Next, the
protein
is threaded through the Sec translocon in an unfolded state.
During
this translocation step, or shortly thereafter, the signal
peptide
is removed by a so-called signal peptidase (SPase). Upon
complete
membrane translocation, the protein has to fold into its
correct
conformation and will then be retained in an extracytoplasmic
compartment
of the cell or secreted into the extracellular milieu. In
the
case of gram-positive cocci, such as
S. aureus (Fig.
1), we
distinguish three extracytoplasmic subcellular compartments,
namely,
the membrane, the membrane-cell wall interface, and
the cell wall.
Since surface-exposed and secreted proteins of
S. aureus play
pivotal roles in the colonization and subversion
of the human host, it
is of major importance to obtain a clear
understanding of the protein
transport pathways that are active
in this organism
(
103). Knowledge about
the protein sorting
mechanism has become all the more relevant with the
emergence
of staphylococcal resistance against last-defense
antibiotics,
such as vancomycin. The scope of this review is to provide
a
state-of-the-art roadmap of staphylococcal secretomes, which
include
both protein transport pathways and the extracytoplasmic
proteins of
staphylococcal organisms. The focus is on
S. aureus,
but
comparisons with
Staphylococcus epidermidis and the
best-characterized
gram-positive bacterium,
Bacillus subtilis,
are included where
appropriate. Importantly, the present review aims to
integrate
the results of genomic and proteomic studies on
S.
aureus secretomes,
representing the first documented
"comparative secretomics"
study. Specifically, this
review deals with known and predicted
exported virulence
factors, pathways for protein transport,
signals for subcellular
protein sorting or secretion, and the
exoproteomes of different
S.
aureus isolates, as defined by
two-dimensional polyacrylamide gel
electrophoresis (2D-PAGE)
and mass spectrometry (Fig.
2 and
3). The
exoproteome is defined
by all
S. aureus proteins that can be
identified in the extracellular
milieu of this organism and thus
includes proteins actively
secreted by living cells and the remains of
dead cells. For
a clear appreciation of the present review, it is
important
to bear in mind that the proteins exported from the cytoplasm
could
be directly involved in staphylococcal virulence, whereas the
respective
protein export systems represent the "pathways to
pathogenesis."

EXPORTED STAPHYLOCOCCAL VIRULENCE FACTORS
S. aureus
and
S. epidermidis are organisms that occur naturally
in and
on the human body. While
S. epidermidis is mostly present
on
human skin,
S. aureus can be found on mucosal surfaces.
S.
aureus is carried by 30 to 40% of the population
(
143) and can be
identified
readily in the nose, but the organism can also be detected
in
other moist regions of the human body, such as the axillae,
perineum,
vagina, and rectum, which thereby form a major reservoir for
infections.
Although most staphylococcal infections are nosocomial
(i.e.,
hospital acquired), an increase in the number of cases of
community-acquired,
antibiotic (methicillin)-resistant infections is
currently being
observed worldwide
(
27,
67,
185). The risk of
intravascular
and systemic infection by
S. aureus rises when
the epithelial
barrier is disrupted by intravascular catheters,
implants, mucosal
damage, or trauma. Interestingly, after infection,
cells of
S. aureus can persist unnoticed in the human body for
a long
time (years), after which they can suddenly cause another
infection.
S. aureus is primarily an extracellular pathogen
whose colonization
and invasion of human tissues and organs can lead to
severe
cytotoxic effects. Nevertheless,
S. aureus can also be
internalized
by various cells, including nonphagocytic cells, which
seems
to induce apoptosis
(
43,
72,
120). Although
S.
aureus has the
potential to form biofilms
(
64),
S.
epidermidis infections are
particularly notorious for the
formation of thick multilayered
biofilms on indwelling catheters and
other implanted devices.
The formation of such a biofilm takes place in
several steps,
during which the bacteria first adhere rapidly to the
surface
of a polymer material that has been coated with a film of
proteinaceous
and nonproteinaceous organic host molecules
(
56). Bacteria that
adhere
to this film produce extracellular polymeric substances, mostly
polysaccharides
and proteins, in turn resulting in a strong attachment
to the
polymer surface and other bacteria in the growing biofilm.
Ultimately,
the biofilm is composed of multiple layers of cells,
cellular
debris, polysaccharides, and proteins.
S. epidermidis
factors
that are essential for biofilm formation include the
polysaccharide
intercellular adhesin
(
107), the
accumulation-associated protein
(
157),
and the
biofilm-associated protein
(
184). Polysaccharide
intercellular
adhesin is most likely identical to the polysaccharide
adhesion
protein.
Virulence of S. aureus
The pathogenicity of
S. aureus is caused by
the expression of
an arsenal of virulence factors (Table
1), which can lead to
superficial skin lesions, such as styes,
furunculosis, and paronychia,
or to more serious infections, such as
pneumonia, mastitis,
urinary tract infections, osteomyelitis,
endocarditis, and even
sepsis. In very rare cases,
S. aureus
causes meningitis. The
virulence factors that
S. aureus
employs to cause these diseases
are displayed at the surface of the
staphylococcal cell or secreted
into the host milieu
(
57). Specifically, these
virulence factors
include (i) surface proteins that promote adhesion to
and colonization
of host tissues, (ii) invasins that are exported to an
extracytoplasmic
location and promote bacterial spread in tissues
(leukocidin,
kinases, and hyaluronidase), (iii) surface factors that
inhibit
phagocytic engulfment (capsule and protein A), (iv) biochemical
properties
that enhance staphylococcal survival in phagocytes
(carotenoid
and catalase production), (v) immunological disguises
(protein
A, coagulase, and clotting factor), (vi) membrane-damaging
toxins
that disrupt eukaryotic cell membranes (hemolysins and
leukotoxin),
(vii) superantigens that contribute to the
symptoms of septic
shock (SEA-G, toxic shock syndrome toxin [TSST], and
ET), and
(viii) determinants for inherent and acquired resistance to
antimicrobial
agents.
Most virulence factors are expressed in a
coordinated fashion
during the growth cycle of
S. aureus. The
best-characterized
regulators of virulence factors are the accessory
gene regulator
(
agr)
(
124,
144,
152) and the
staphylococcal accessory regulator
(SarA)
(
29,
30). Ziebandt et al.
(
208) showed that
extracellular
proteins can be divided into two groups based on the
timing
of their expression in cells grown in tryptic soy broth (TSB),
i.e.,
proteins that are expressed only at low cell densities and
proteins
exclusively expressed at high cell densities.
agr
seems to be
an important positive regulator of proteins that are
expressed
at higher optical densities (e.g., proteases, hemolysins, and
lipases)
and a negative regulator of proteins that are expressed during
the
exponential growth phase (e.g., immunodominant antigen A, secretory
antigen
precursor, and several proteins with unknown functions). In
addition,
Gill et al.
(
63) identified 15 other
two-component regulatory
systems in the genomes of
S. aureus
and
S. epidermidis that
are potentially involved in
staphylococcal virulence. In this
respect, it is interesting that the
antibiotic cerulenin, which
is known to inhibit protein secretion by
S. aureus at sub-MIC
levels, was recently reported to block
the transcriptional activation
of at least two regulatory determinants,
agr and
sae. Thus,
it seems that cerulenin inhibits
the transcription of genes
for secretory proteins rather than the
secretion process of
these proteins
(
1). In contrast, it was
previously believed
that cerulenin would interfere with membrane
function through
an inhibition of normal fatty acid
synthesis.
Notably, to date, relatively little information is
available on the molecular nature of the stimuli that are perceived by
the major regulators of the expression of virulence factors. Overall,
it should be clear that strain-specific differences in gene regulation
by agr, sae, sarA, or other regulators may
dramatically influence the repertoire of produced virulence factors,
thereby having a profound impact on the disease-causing potential of
different strains. Since the interplay of different regulators and
cell-to-cell communication can impact differently on the expression of
different virulence factors, even the disease-causing potential of
individual S. aureus cells within a genetically identical
population may vary.
Resistance of S. aureus to Antibiotics
Resistance of
S. aureus to
antibiotics was observed very soon
after the introduction of penicillin
about 60 years ago. In
the following years, the amazing ability of
staphylococci to
develop resistance to antibiotics has
resulted in the emergence
of methicillin-resistant
S. aureus (MRSA) and
S. epidermidis strains. In fact,
methicillin resistance was observed already
in 1961 in nosocomial
isolates of
S. aureus, 1 year after the
introduction of
methicillin (
85).
Resistance towards methicillin
is a result of the production of an
altered penicillin binding
protein, PBP2a (or PBP2'), which has
less affinity for most
ß-lactam antibiotics. The PBP2a protein,
which is
located at the membrane-cell wall interface, is of major
importance
for cell wall biogenesis by mediating the cross-linking of
peptidoglycans.
PBP2a is encoded by the
mecA gene, which is
located on a mobile
genetic element known as the staphylococcal
cassette chromosome
mec element (SCC
mec)
(
28,
84). SCC
mec is a
basic mobile genetic
element that serves as a vehicle for gene exchange
among staphylococcal
species
(
49). In addition to the
mecA gene, SCC
mec carries the
mecA
regulatory genes
mecI and
mecR, an insertion sequence
element
(IS
431mec), and a unique cassette of recombinase genes
(
ccr),
which are responsible for SCC
mec chromosomal
integration and
excision. Five different types of SCC
mec
elements, types I to
V, have been identified so far, based on the
classes of
mecA gene and
ccr gene complexes
(
84). The type I
SCC
mec contains
the
mecA gene as the only resistance
element, while the type
II and III elements contain, besides
mecA, multiple determinants
for resistance against
non-ß-lactam antibiotics. Accordingly,
type II and III
SCC
mec elements are responsible for multidrug
resistance in
nosocomial MRSA isolates. Type IV SCC
mec elements,
like type I
elements, contain no resistance genes other than
mecA, and
they are significantly smaller than the type II and
III elements. This
might serve as an evolutionary advantage,
making it easier for these
mobile genetic elements to spread
across bacterial populations. Type V
SCC
mec elements are also
small compared to the other elements
and differ in their set
of recombinase genes
(
84). Whereas the type I
to IV SSC
mec elements
contain the two recombinase genes
ccrA and
ccrB, the type V
elements contain a single
copy of a gene,
ccrC, homologous to
a cassette chromosome
recombinase gene. In addition, two open
reading frames,
hsdS
and
hsdM, which encode a restriction-modification
system, are
unique to these elements. Phylogenetic analyses
of these genes showed a
distant relationship with their homologues
in other
S. aureus
genomes and suggested a foreign origin for
these
genes.
Vancomycin resistance was first reported for
Enterococcus faecium
(101), and transfer of
vancomycin resistance from enterococci, such as Enterococcus
faecalis, to S. aureus has been shown to occur
(137). Vancomycin has
long been a last-resort antibiotic for multiple-drug-resistant S.
aureus strains, but already in 1996 a strain was
isolated which showed reduced sensitivity towards vancomycin
(78). Shortly afterwards,
additional strains were isolated in different countries and were
designated vancomycin intermediately resistant S. aureus
(VISA). These strains show a significantly thickened cell wall, which
allows them to sequester more vancomycin than non-VISA strains, thereby
preventing the detrimental effects of this antibiotic
(42). A search for the
genetic basis of the lowered vancomycin sensitivity of the S.
aureus Mu50 strain revealed that important genes for cell wall
biosynthesis and intermediary metabolism have mutations compared to
those in MRSA strains, which might lead to altered expression of genes
involved in cell wall metabolism and a thickened cell wall
(4). The first
highly-vancomycin-resistant strain was isolated in 2002
(199). This strain was
shown to carry a plasmid which contains, among other resistance genes,
the vanA gene plus several additional genes required for
vancomycin resistance. The proteins encoded by these genes are
responsible for replacing the C-terminal
D-alanyl-D-alanine
(D-Ala-D-Ala) of the
disaccharide pentapeptide cell wall precursor with a
depsipeptide,
D-alanyl-D-lactate
(D-Ala-D-Lac), thereby lowering the cell
wall affinity for vancomycin
(24).
Export of Virulence Factors from the Cytoplasm
Since most
proteinaceous virulence factors are displayed at
the surface of the
staphylococcal cell or released into the
medium, it is important for
our understanding of the pathogenic
potential of these organisms to map
their pathways for protein
transport. While specific questions relating
to surface display
or secretion of particular virulence factors have
been addressed
for several years, more holistic studies on the genomics
and
proteomics of these processes have been documented in the
scientific
literature only very recently. Moreover, no systematic
analysis
of pathways and cellular machinery for protein transport has
thus
far been performed for staphylococci. This review is aimed at
filling
this knowledge gap. To do so, we have taken full advantage of
the
availability of six completely sequenced and annotated
S.
aureus genomes and one of the two sequenced
S.
epidermidis strains
as well as recently published data on the
analysis of staphylococcal
cell wall proteomes and exoproteomes.
Additionally, we have
combined published information with
bioinformatics-derived data
on all potential signals for protein export
from the cytoplasm
and secretion into the extracellular milieu or
retention in
the membrane or cell wall. Since polytopic membrane
proteins
do not appear to have major direct roles in virulence other
than
causing drug resistance, such membrane proteins remain beyond
the
scope of this review. Furthermore, since the secretome of
B.
subtilis has been characterized extensively, at the level
of both
the protein export machinery and the exoproteome, we
have compared the
staphylococcal secretomes with that of
B. subtilis. To our
knowledge, this has resulted in the first "comparative
secretomics"
study.

S. AUREUS STRAINS SUITABLE FOR COMPARATIVE SECRETOMICS
Nine sequenced and fully annotated genomes of
S. aureus are
available
in public databases (Table
2) (
http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi;
http://www.tigr.org),
and
six of these genomes were used in the present study. These include
the
genome of one of the first hospital-acquired MRSA isolates,
S.
aureus COL (
63),
which has been used widely in research on
staphylococcal methicillin
and vancomycin resistance. The sequenced
MRSA252 strain
(
79) is a
hospital-acquired epidemic strain,
which was isolated from a patient
who died as a consequence
of septicemia. The sequenced MSSA476 strain
(
79) is a
community-acquired
invasive strain that is penicillin and fusidic acid
resistant
but susceptible to most commonly used antibiotics.
S.
aureus Mu50 and N315
(
100) are
hospital-acquired MRSA strains isolated
from Japanese patients. In
addition, the Mu50 strain displays
intermediate vancomycin sensitivity.
Finally, the community-acquired
isolate
S. aureus MW2
(
7) is a highly virulent
MRSA strain isolated
from a 16-month-old girl from the United States.
Notably, the
most widely used laboratory strain, NCTC8325, has been
sequenced,
but the nucleotide sequence and corresponding annotation
were
not available for the present analyses. This was also the case
for
the community-acquired MRSA strain USA300
(
46). Furthermore,
the
sequence of
S. aureus RF122, a strain associated with mastitis
in
cattle, is now also available in the NCBI database (unpublished),
but
it was not included in the present review, which is primarily
focused
on staphylococcal pathogenicity towards humans. Using
multilocus
sequence typing with seven housekeeping genes of the
different
S. aureus strains, Holden et al.
(
79) showed that the
MRSA252
strain is phylogenetically most distantly related to the other
sequenced
strains, while the Mu50 and N315 strains are
indistinguishable
by multilocus sequence typing, as are the MSSA476 and
MW2 strains.
The COL and NCTC8325 strains are relatively closely
related
to each other.
Sequenced and annotated genomes
of other staphylococcal species,
such as
S.
epidermidis,
Staphylococcus haemolyticus,and
Staphylococcus carnosus, are also publicly
available. However, with the exception
of
S. epidermidis
strain ATCC 12228 (
207),
these are not included
in the present review, which focuses primarily
on
S. aureus.
A comparative genomic analysis of
S.
aureus COL, Mu50, MW2,
and N315 and the sequenced
S.
epidermidis strains RP62a and
ATCC 12228 revealed that these
species and strains have a set
of 1,681 genes in common
(
63). In contrast, 454
genes are present
in the
S. aureus strains but not in
S.
epidermidis, whereas
286 genes are present in
S.
epidermidis but not in
S. aureus.
Most of the
strain-specific and species-specific genes can be
related to the
presence or absence of particular prophages and
genomic
islands.

PATHWAYS FOR STAPHYLOCOCCAL PROTEIN TRANSPORT
The
bacterial machinery for protein transport is currently best
described
for
Escherichia coli (gram negative) and
B. subtilis
(gram
positive) (for reviews, see references
44,
174, and
175). Many
of the known
components that are involved in the different routes
for protein export
from the cytoplasm and in posttranslocational
modification of exported
proteins in these organisms are also
conserved in
S. aureus
and
S. epidermidis (Table
3). In general,
proteins that are exported are synthesized with an
N-terminal
signal peptide, which directs them to a particular transport
pathway.
Consequently, the presently known signal peptides are
classified
according to the export pathway into which they direct the
corresponding
proteins or the type of signal peptidase that is
responsible
for their removal (processing) upon membrane translocation.
The
staphylococcal protein export pathways that have been characterized
experimentally
or that can be deduced from sequenced genomes are shown
schematically
in Fig.
4 and are discussed below. Since these pathways are
likely used for the
export of virulence factors to the cell
surface and the milieu of the
host, Fig.
4 can be
regarded as
a subcellular road map to staphylococcal
pathogenesis.
Components of the Sec Pathway
The most commonly used pathway for bacterial protein transport
is
the general secretory (Sec) pathway. Specifically, this pathway
is
responsible for the secretion of the majority of the proteins
found in
the exoproteome of
B. subtilis, which is probably also
the
case for most other gram-positive bacteria, including
S.
aureus (
174).
Unfortunately, there are very few published data available
concerning
the Sec pathway of
S. aureus, and therefore we have
filled in
the current knowledge gaps with data obtained from
studies of
B.
subtilis or
E. coli. Proteins that are exported
via the
Sec pathway contain signal peptides with recognition
sites for
so-called type I or type II SPases. Notably, type
II SPase recognition
sites overlap with the recognition sites
for the diacylglyceryl
transferase Lgt. Precursor proteins with
a type II SPase recognition
sequence are lipid modified prior
to being processed, and the resulting
mature proteins are retained
as lipopoteins in the cytoplasmic membrane
via their diacylglyceryl
moieties. Furthermore, the Sec-dependent
export of proteins
can be divided into the following three stages: (i)
targeting
to the membrane translocation machinery by export-specific or
general
chaperones, (ii) translocation across the membrane by the Sec
machinery,
and (iii) posttranslocational folding and modification. If
the
translocated proteins of gram-positive bacteria lack specific
retention
signals for the membrane or cell wall, they are secreted into
the
growth medium.
Preprotein targeting to the membrane.
In B. subtilis, the
only known secretion-specific chaperone is the signal recognition
particle (SRP), which consists of small cytoplasmic RNA (scRNA), the
histone-like protein HBsU, and the Ffh protein. Ffh and HBsU bind to
different moieties of the scRNA. Studies with E. coli have
shown that upon emergence from the ribosome, the signal peptide of a
nascent secretory protein can be recognized by several cytoplasmic
chaperones and/or targeting factors, such as Ffh or trigger factor (TF)
(55). In contrast to Ffh,
which is required for cotranslational protein export in E.
coli, the cytoplasmic chaperone SecB has mainly been implicated in
posttranslational protein targeting. Notably, however, SecB is absent
from the sequenced gram-positive bacteria, including S. aureus
and B. subtilis. Most likely, ribosome-nascent chain complexes
of S. aureus are thus targeted to the membrane by SRP, which,
by analogy to the case in B. subtilis and E. coli,
will probably involve the SRP receptor FtsY. At the membrane, the
nascent preprotein will be directed to the translocation machinery.
This process is likely stimulated by negatively charged phospholipids
(45), the Sec translocon
(17,
45), and/or the SecA
protein (25). In this
respect, SecA may function not only as the translocation motor (see
below) but also as a chaperone for preprotein targeting
(75). While it has been
shown that Ffh is essential for growth and viability in E.
coli and B. subtilis, this does not seem to be the case
for all bacteria. For example, Ffh, FtsY, and scRNA are not essential
in Streptococcus mutans. In this organism, the SRP is merely
required for growth under stressful conditions, such as low pH
(<pH 5), high salt (3.5% NaCl), or the presence of
H2O2 (0.3 mM). This suggests that SRP has an
important role in the export of proteins to the membrane or cell wall
to protect S. mutans against environmental insults
(71).
For B.
subtilis, it has been proposed that the general chaperone CsaA may
have a role in preprotein targeting to the membrane, similar to SecB of
E. coli. This view is supported by the observation that the
B. subtilis CsaA protein has binding affinity for SecA and
preproteins (126).
However, CsaA is not conserved in S. aureus. Therefore, it
remains to be investigated whether other chaperones with a preprotein
targeting function are present in S.
aureus.
Translocation across the membrane.
As deduced from known genome
sequences, the translocation machinery of S. aureus consists
of several Sec proteins. The mode of action of these proteins has been
studied in great detail in E. coli
(44,
197). After binding of a
preprotein to a SecA dimer, the SecA molecules will bind ATP, resulting
in conformational changes that promote their insertion together with
the preprotein into the membrane-embedded translocation channel.
Subsequent hydrolysis of ATP causes SecA to release the preprotein,
return to its original conformation, and deinsert from the
translocation channel. Repeated cycles of ATP binding and hydrolysis by
SecA, together with the proton motive force, drive further
translocation of the preprotein across the membrane. The translocation
channel is essentially formed by the SecE and SecY proteins, which are
conserved in all bacteria
(189). An additional
nonessential channel component is SecG, which serves to increase the
translocation efficiency. While the SecY proteins of different bacteria
show a relatively high degree of sequence similarity, the SecE and SecG
proteins, though present in all bacteria, are less well conserved.
Specifically, the SecE and SecG proteins in B. subtilis,
S. aureus, and S. epidermidis are considerably
shorter than the equivalent proteins of E. coli. Although SecA
and SecY of S. aureus (referred to here as SecA1 and SecY1)
have not yet been characterized functionally, they are of major
importance for the growth of S. aureus. This was demonstrated
with the help of specific antisense RNAs
(86). Upon secA
antisense induction, a strong growth defect was observed, and
secY antisense induction turned out to be
lethal.
Remarkably, the genome of S. aureus contains a
second set of secA and secY genes, referred to as
secA2 and secY2, respectively. In contrast to the
SecA1 and SecY1 proteins, their homologues are not essential for growth
and viability. It is presently unknown whether SecA2 and SecY2
transport specific proteins across the membrane of S. aureus.
However, it has been shown for other pathogenic gram-positive bacteria
which also possess a second set of SecA and SecY proteins that these
proteins are required for the transport of certain proteins related to
virulence. In Streptococcus gordonii, the export of GspB, a
large cell surface glycoprotein that contributes to platelet binding,
seems to be dependent on the presence of SecA2 and SecY2
(13). This protein
contains large serine-rich repeats, an LPXTG motif for cell wall
anchoring (see below), and a very large signal peptide of 90 amino
acids. In Streptococcus parasanguis, two other proteins, FimA
and Fap1, are known to be secreted via SecA2-dependent membrane
translocation. FimA is a (predicted) lipoprotein which is a major
virulence factor implicated in streptococcal endocarditis. The FimA
homologue in S. aureus is a manganese-binding lipoprotein
(MntA) associated with an ATP-binding cassette (ABC) transporter. Fap1
of S. parasanguis is involved in adhesion to the surfaces of
teeth. Like FimA, Fap1 has a long signal peptide of 50 amino acids,
serine-rich repeats, and an LPXTG motif for cell wall anchoring. To
date, it is not known what determines the difference in specificity of
the SecA1/SecY1 and SecA2/SecY2 translocases. It is also not known
whether the SecA2/SecY2 translocase shares SecE and/or SecG with the
SecA1/SecY1 translocase, whether these translocases function completely
independently from each other, or whether mixed translocases can occur.
Clearly, the secE and secG genes are not duplicated
in S. aureus. The SecE and SecG functions in the SecA2/SecY2
translocase may, however, be performed by the S. aureus
homologues of the Asp4 and Asp5 proteins of S. gordonii, for
which SecE- and SecG-like functions have been proposed
(172).
In E.
coli, the heterotrimeric SecYEG complex is associated with another
heterotrimeric complex composed of the SecD, SecF, and YajC proteins
(138). This complex has
been shown to be involved in the cycling of SecA
(51) and the release of
the translocated protein from the translocation channel
(113). SecD and SecF are
separate but structurally related proteins in most bacteria, including
E. coli. Interestingly, in B. subtilis and S.
aureus, natural gene fusions between the secD and
secF genes are observed. Accordingly, the corresponding SecDF
proteins can be regarded as molecular "Siamese twins"
(20). Unlike SecA, SecY,
and SecE, the SecDF protein of B. subtilis is not essential
for growth and viability, and its role in protein secretion is
presently poorly understood
(20). B. subtilis
secDF mutants showed only a mild secretion defect under conditions
of high-level synthesis of secretory proteins. The known SecDF proteins
have 12 (predicted) transmembrane domains with two large
extracytoplasmic loops, between the first and second transmembrane
segments and between the seventh and eighth transmembrane segments. For
E. coli SecD, it has been shown that small deletions in the
large extracytoplasmic loop result in malfunctioning of the protein,
while the stability of the SecDF-YajC complex is not affected
(138). It has therefore
been proposed that this loop in SecD might provide a protective
structure in which translocated proteins can fold more efficiently. The
large extracytoplasmic loop in SecF has been proposed to interact with
SecY, thereby stabilizing the translocation channel formed by SecYEG.
Homologues of the E. coli YajC protein are present in many
bacteria, including S. aureus and B. subtilis (YrbF),
but their role in protein secretion has not yet been established. It is
presently not known whether the S. aureus SecDF-YajC complex
associates specifically with the SecA1/SecY1 translocase, the
SecA2/SecY2 translocase, or both.
Type I signal peptidases.
Signal peptides of
preproteins are cleaved during or shortly after translocation by an
SPase I or SPase II, depending on the nature of the signal peptide
(180,
187). The B.
subtilis chromosome encodes five type I SPases, named SipS, SipT,
SipU, SipV, and SipW
(176,
178,
186). Two of these, SipS
and SipT, are of major importance for the processing of secretory
preproteins, growth, and viability. In S. aureus, only two
SPase I homologues are present, namely, SpsA and SpsB. The
catalytically active SPase I in S. aureus is SpsB, which is
probably essential for growth and viability
(38). This SPase can be
used to complement an E. coli strain that is temperature
sensitive for preprotein processing. In general, type I SPases
recognize residues at the 1 and 3 positions relative
to the cleavage site
(187). For B.
subtilis, it has been shown that all secretory proteins identified
by proteomics have Ala at the 1 position and that 71% of these
secretory proteins have Ala at the 3 position
(174). In contrast,
various residues are tolerated at the 2 position, including
Ser, Lys, Glu, His, Tyr, Gln, Gly, Phe, Leu, Ala, Asp, Asn, Trp, and
Pro. Interestingly, Bruton et al.
(23) studied the cleavage
sites in substrates of S. aureus SpsB and showed that this
enzyme has a preference for basic residues at the 2 position
and tolerance for hydrophobic residues at this position. However, an
acidic residue at the 2 position resulted in a significantly
reduced rate of processing. The second SPase I homologue of S.
aureus (SpsA) appears to be inactive, since it lacks the catalytic
Ser and Lys residues, which are replaced with Asp and Ser residues,
respectively. The presence of an apparently catalytically inactive SpsA
homologue is a conserved feature of all staphylococci with sequenced
genomes. Notably, in addition to an inactive SpsA homologue, S.
epidermidis contains two SpsB homologues, which show the greatest
similarity to SipS and SipU of B. subtilis. To date, it is not
known whether the inactive SpsA homologues contribute somehow to
protein secretion in these
organisms.
Lipid modification of lipoproteins.
In E. coli, lipid
modification of prolipoproteins involves three sequential steps that
are catalyzed by cytoplasmic membrane-bound proteins. The first step
involves the transfer of a diacylglyceryl group from
phosphatidylglycerol to the sulfhydryl group of the invariant Cys
residue present at the +1 position of the signal peptide
cleavage site in lipoprotein precursors. This step is catalyzed by a
phosphatidyl glycerol diacylglyceryl transferase (Lgt), as shown for
E. coli by Sankaran and Wu
(161). The recognition
sequence for Lgt, which includes the Cys residue that becomes modified
with diacylglyceryl, is known as the lipobox. Lipid modification of the
lipobox Cys residue is necessary for the lipoprotein-specific type II
signal peptidase (LspA) to recognize and cleave the signal peptide of a
prolipoprotein, which represents the second step in lipoprotein
modification. The third step involves the transfer of an
N-acyl group by an N-acyl transferase (Lnt),
resulting in the formation of N-acyl diacylglycerylcysteine at
the N terminus of the mature lipoprotein. Although Lgt and LspA are
present in most, if not all, bacteria, Lnt is present only in
gram-negative bacteria
(180). Like the case for
other gram-positive bacteria, no homologue of Lnt could be detected in
the genomes of S. aureus or S. epidermidis
(169), which suggests
that the lipoproteins of these organisms are not N
acylated.
S. aureus Lgt is a protein of 279 amino acids
that contains a highly conserved HGGLIG motif (residues 97 to 102).
Although the His residue in this motif was shown to be essential for
the catalytic activity of E. coli Lgt
(160), it is not
strictly conserved in all known Lgt proteins. On the other hand, the
strictly conserved Gly at position 103 of E. coli Lgt, which
is equivalent to Gly98 of S. aureus Lgt, is required for the
activity of this protein. Stoll et al.
(169) showed that an
S. aureus lgt mutation has no effect on growth in broth, as
also observed for B. subtilis
(104). Nevertheless, the
absence of Lgt has a considerable effect on the induction of an
inflammatory response. Importantly, lipid modification serves to retain
exported proteins at the membrane-cell wall interface. This is
particularly relevant for gram-positive bacteria, which lack an outer
membrane that represents a retention barrier for exported proteins. In
the absence of Lgt, B. subtilis cells release a variety of
lipoproteins into the extracellular milieu, in the form of both
unmodified precursor proteins and alternatively processed mature
proteins that lack the N-terminal Cys residue
(3). Similarly, the S.
aureus lgt mutation resulted in the shedding of certain abundant
lipoproteins, such as OppA, PrsA, and SitC, into the broth. These
lipoproteins are normally retained in the membrane or cell wall of
S. aureus.
Type II signal peptidase.
As described above, lipoprotein
signal peptides of prolipoproteins are cleaved by type II SPases after
the Cys residue in the lipobox is modified by Lgt. Although B.
subtilis and many other bacteria contain only one copy of the
lspA gene, some organisms, such as S. epidermidis,
Bacillus licheniformis, and Listeria monocytogenes,
contain a second copy. LspA is a membrane protein that spans the
membrane four times, and both its N and C termini face the cytoplasmic
side of the membrane
(178,
188). Six amino acid
residues are important for SPase II activity, of which two Asp residues
form the active site
(178). While processing
of lipoproteins by LspA is essential for growth and viability
for E. coli and other gram-negative bacteria
(202), it is not
essential for B. subtilis
(177) and other
gram-positive bacteria, such as Lactococcus lactis
(190). This suggests
that processing of prolipoproteins is not essential for their
functionality. This view is supported by the fact that PrsA, a
lipoprotein required for correct folding of translocated proteins, is
essential for viability of B. subtilis
(99). In the absence of
LspA, some of the lipoproteins of B. subtilis are processed in
an alternative way by unidentified proteases, and the activity of
unprocessed lipoproteins in lspA mutants is reduced. Also, in
these B. subtilis mutants, secretion of the nonlipoprotein
AmyQ was severely reduced
(177). This reduction
might be the consequence of a malfunction of unmodified PrsA in AmyQ
folding. Although most lspA mutants have been studied in
gram-negative bacteria and a few nonpathogenic gram-positive bacteria
(177,
190), Sander et al.
(159) showed a severely
attenuated phenotype of lspA mutants of the pathogen
Mycobacterium tuberculosis, which implies an important role
for lipoprotein processing by LspA during infection with M.
tuberculosis. In S. aureus, both the lspA and
lgt genes are present as single copies in the genomes of all
six sequenced strains. Interestingly, one of the two LspA homologues in
S. epidermidis (125 amino acids) is considerably shorter than
other known LspA proteins, including its large paralogue (177 amino
acids). This is mainly the result of an additional N-terminal
transmembrane domain in the large LspA proteins. As a result, the short
S. epidermidis LspA protein is predicted to have three
membrane-spanning domains, with the N terminus located on the outside
of the cell, the C terminus located on the inside of the cell, and the
(putative) active-site Asp residues located on the outer surface of the
cytoplasmic membrane.
Signal peptide peptidase.
After translocation and
processing of the preproteins by signal peptidases, the signal peptides
are rapidly degraded by signal peptide peptidases (SPPases). In B.
subtilis, two SPPases, TepA and SppA, are known to be involved in
translocation and processing of preproteins
(21). While TepA is
required for translocation and processing of preproteins, SppA is
required only for efficient processing of preproteins. Remarkably, no
homologues of SppA or TepA were detectable by BLAST searches in the
sequenced genomes of S. aureus and S. epidermidis. As
reported by Meima and van Dijl
(119), L.
lactis contains a protein that shows limited similarity
to TepA of B. subtilis and ClpP of
Caenorhabditis elegans, suggesting that
this protein might be an SPPase analog in L. lactis. In S.
aureus and S. epidermidis, this protein homologue also
seems to be present and is predicted to be a cytoplasmic membrane
protein (our unpublished
observations).
Folding catalysts (PrsA and BdbD).
Proteins that are transported
across the membrane in a Sec-dependent manner emerge at the
extracytoplasmic membrane surface in an unfolded state. These proteins
need to be rapidly and correctly folded into their native and
protease-resistant conformation before they are degraded by proteases
in the cell wall or extracellular environment
(162). An important
folding catalyst in B. subtilis is PrsA, which shows homology
to peptidyl-prolyl cis/trans-isomerases. PrsA is a
lipoprotein (see "Lipoproteins" below) that is
essential for efficient protein secretion and cell viability in B.
subtilis (99,
162). Studies on the
effects of PrsA depletion showed that the relative amounts of
extracellular proteins from PrsA-depleted cells were significantly
reduced (192). No data
have been published on S. aureus mutants lacking PrsA, and it
will be interesting to investigate whether PrsA is also essential for
the viability and virulence of this organism. It has already been shown
that S. aureus lacking Lgt releases an increased amount of
PrsA into the extracellular milieu
(169), which might
indicate that (most) pre-PrsA is not fully functional but is sufficient
for viability. The observation by Stoll et al.
(169) also shows that,
like the case in B. subtilis
(3), unmodified pre-PrsA
is not effectively retained in the cytoplasmic membrane.
Other
proteins that are involved in proper folding of extracellular proteins
in B. subtilis are the membrane proteins BdbC and BdbD, which
are involved in the formation of disulfide bonds. Both proteins have
been shown to be necessary for stabilization of the
membrane- and cell wall-associated pseudopilin
ComGC (118). This
protein, which is required for DNA binding and uptake during natural
competence, contains an intramolecular disulfide bond
(31). Both BdbC and BdbD
are also important for the folding of heterologously produced E.
coli PhoA, which contains two disulfide bonds, into an active and
protease-resistant conformation
(21,
118). Although a
homologue of BdbD (named DsbA) is present in S. aureus, there
is no homologue of BdbC in this organism. The same appears to be true
for S. epidermidis. Nevertheless, measurements of the redox
potential of purified DsbA indicated that this protein can act as an
oxidase, and this view was confirmed by complementation studies with a
dsbA mutant strain of E. coli
(53). The absence of a
BdbC homologue in the staphylococci is remarkable, since B.
subtilis BdbC and BdbD are jointly required for the folding of
ComGC and E. coli PhoA. Notably, all sequenced S.
aureus genomes encode homologues of ComGC, including the Cys
residues that form the disulfide bond in B. subtilis ComGC.
This raises the question of whether ComGC of S. aureus does
indeed contain a disulfide bond and, if so, which protein(s) is
involved in the formation of this disulfide bond. Notably, S.
aureus DsbA was recently shown to be a lipoprotein that does not
seem to contribute to the virulence of this organism, as tested in
mouse and Caenorhabditis elegans models
(53). Furthermore, DsbA
was shown to be dispensable for ß-hemolysin activity, despite
the fact that this protein contains a disulfide bond, which is required
for activity (54).
Therefore, the biological function of DsbA in staphylococci remains to
be elucidated.
Tat Pathway
The twin-arginine translocation (Tat) pathway exists in many
bacteria,
archaea, and chloroplasts. This pathway was named after the
consensus
double (twin) Arg residues that are present in the signal
peptide.
The twin Arg residues are part of a motif that directs
proteins
specifically into the Tat pathway. In contrast to the Sec
machinery,
where only unfolded proteins are translocated across the
membrane,
the Tat machinery is capable of translocating folded
proteins.
In gram-negative bacteria, streptomycetes, mycobacteria, and
chloroplasts,
an active Tat pathway seems to require three core
components,
named TatA, TatB, and TatC
(
14,
47,
125,
154,
204). In all
gram-positive
bacteria except streptomycetes and
Mycobacterium
smegmatis,
the Tat pathway involves only TatA and TatC
(
47,
204). Recent
studies
with
E. coli and chloroplasts have resulted in a model
that
proposes key roles for TatB-TatC complexes in signal peptide
reception
and for TatA-TatB-TatC complexes in preprotein translocation
(
2,
36).
Interestingly,
certain mutations in
E. coli TatA have been shown
to allow
this protein to compensate for the absence of TatB
(
18).
This demonstrates
that TatA is intrinsically bifunctional, which
is consistent with the
fact that most gram-positive bacteria
lack TatB but have TatA
(
90). In
B.
subtilis, two minimal TatA-TatC
translocases with distinct
specificities are active
(
88). While
the
constitutively expressed TatAy-TatCy translocase of
B.
subtilis is required for secretion of a protein with unknown
function,
YwbN, the TatAd-TatCd translocase seems to be expressed only
under
conditions of phosphate starvation for secretion of the
phosphodiesterase
PhoD
(
175,
188). Most other
gram-positive bacteria that have
tatA and
tatC genes,
including
S. aureus, appear to have only
one TatA-TatC
translocase. The functionality of the
S. aureus Tat
translocase remains to be demonstrated. In contrast to
S.
aureus,
S. epidermidis seems to lack a Tat
pathway.
Pseudopilin Export (Com) Pathway
In
B. subtilis, four proteins, ComGC, ComGD,
ComGE, and ComGG,
have been identified as having an N-terminal
pseudopilin-like
signal peptide
(
174,
175). All four of these
proteins are involved
in DNA binding and uptake and are localized in
the membrane
and cell wall. It is thought that these proteins form a
pilus-like
structure in the cell wall or modify the cell wall to
provide
a passage for DNA uptake. Translocation to the extracytoplasmic
membrane
surface is possible only when these proteins are processed by
the
pseudopilin-specific SPase ComC in
B. subtilis
(
52). SPases
of this type
are bifunctional and catalyze not only signal peptide
cleavage but also
methylation of the N terminus of the mature
protein
(
170). Furthermore,
export and functionality of the
four ComG proteins depend on the
integral membrane protein ComGB
and the traffic ATPase ComGA, which is
located at the cytoplasmic
side of the membrane
(
32,
69). Homologues of ComC,
ComGA, ComGB,
and ComGC, but not ComGD, ComGE, and ComGG, are present
in the
six sequenced
S. aureus strains. This suggests that the
Com
system of
S. aureus is not involved in DNA uptake but is
part
of another solute transport
process.
ABC Transporters
Bacteriocins are peptides or proteins that inhibit the
growth
of other bacteria. Most of the characterized bacteriocins can
be
divided into several classes, depending on specific posttranslational
modifications,
the presence and processing of particular leader
peptides, and
the machinery for export from the cytoplasm. A
well-described
class of bacteriocins is formed by the lantibiotics.
Members
of this class are composed of short peptides that contain
posttranslationally
modified amino acids, such as lanthionine and
ß-methyllanthionine
(
117).
The production of
bacteriocins in
S. aureus has been described
for various
strains.
S. aureus C55 produces the two lantibiotics
C55
and C55ß
(
129). These
lantibiotics are both encoded
by a 32-kb plasmid, which is readily lost
upon growth at elevated
temperatures. C55

and C55ß
showed antimicrobial activity
towards other
S. aureus strains
and
Micrococcus luteus but not
towards
S.
epidermidis. Furthermore, the nonlantibiotics BacR1
(
40),
aureocin A53
(
134), and aureocin A70
(
132,
133) have been
identified
as bacteriocins with activity against a broad range of
bacteria.
The genes for both aureocins are located on a
plasmid that is
present in
S. aureus strains isolated from
milk. By analogy
with the well-described bacteriocin export machineries
of other
organisms (
73,
145), it can be
anticipated that all of the aforementioned
bacteriocins are exported to
the external staphylococcal milieu
by dedicated ABC transporters.
However, no experimental evidence
for this assumption has been
published for
S. aureus. Notably,
it has been demonstrated
that secretion of the lantibiotics
epidermin and gallidermin of
S.
epidermidis Tü3298 and
Staphylococcus gallinarum,
respectively, is facilitated by so-called
one-component ABC
transporters. Specifically, the ABC transporter
GdmT has been
implicated in the transport of these lantibiotics
(
145).
Holins
Holins are dedicated export systems for peptidoglycan-degrading
endolysins
that have been implicated in the programmed cell death of
bacteria.
These exporters, which are composed of homo-oligomeric
complexes,
can be subdivided into two classes, depending on the number
of
transmembrane segments. While class I holin subunits have three
transmembrane
segments, class II holin subunits have two transmembrane
segments
(
206). In
S. aureus, the
lrg and
cid operons are
involved in
murein hydrolase activity and antibiotic tolerance
(
66,
153).
A disrupted
lrg operon leads to an increase in murein hydrolase
activity
and a decrease in penicillin tolerance, and a disrupted
cid
operon leads to a decrease in murein hydrolase activity
and an increase
in penicillin tolerance. It is still unclear
how the CidA and LrgA
proteins are involved in these mechanisms,
but these proteins display
significant similarity to the bacteriaphage
holin protein family,
suggesting that they have a role in protein
export. It has therefore
been proposed that the CidA and LrgA
proteins act on murein hydrolase
activity and antibiotic tolerance
in a manner analogous to that of
holins and antiholins, respectively
(
11,
153).
Sequence
similarity searches showed that the genes for LrgA
and CidA are
conserved in the six sequenced
S. aureus strains
as well as in
S. epidermidis and
B. subtilis. Notably, none
of the
three holins of
B. subtilis were shown to be involved
in the
secretion of proteins to the extracellular milieu
(
174,
200).
ESAT-6 Pathway
The ESAT-6 secretion pathway was first described for
M. tuberculosis.
It has been proposed that at least two
virulence factors, ESAT-6
(early secreted antigen target, 6 kDa) and
CFP-10 (culture filtrate
protein, 10 kDa), are secreted via this
pathway in a Sec-independent
manner
(
16,
166). Since this pathway
was discovered in mycobacteria,
it is also known as the Snm pathway
(secretion in mycobacteria)
(
37).
The genes for
ESAT-6 and CFP-10 are located in conserved gene
clusters, which also
encode proteins with domains that are conserved
in FtsK- and
SpoIIIE-like transporters. These conserved FtsK/SpoIIIE
domains have
been termed FSDs (
26). In
other gram-positive bacteria,
including
S. aureus,
B. subtilis,
Bacillus anthracis,
Clostridium acetobutylicum, and
L.
monocytogenes, homologues of ESAT-6 have
been
identified (
140). The
genes for these ESAT-6 homologues
are also found in gene clusters that
contain at least one gene
for a membrane protein with an FSD. In
S.
aureus, two proteins,
named EsxA and EsxB, have been identified
that seem to be secreted
via the ESAT-6 pathway
(
26). The
esxA
and
esxB genes are part
of a cluster containing six other
genes for proteins that have
been implicated in the translocation of
EsxA and EsxB. These
include the EsaB and EsaC proteins, with a
predicted cytoplasmic
location, as well as the predicted membrane
proteins EsaA, EssA,
EssB, and EssC, among which EssC contains an FSD.
Mutations
in
essA,
essB, or
essC result in a
loss of EsxA and EsxB production,
which may be related to inhibition of
the synthesis of these
proteins or their folding into a
protease-resistant conformation.
All sequenced
S. aureus
strains contain this cluster of
esa,
ess, and
esx genes, but it seems to be absent from
S.
epidermidis.
Interestingly, the genes for EsxB and EsaC appear to
be absent
from the
S. aureus MRSA252 strain. This implies that
the ESAT-6
machinery of this strain may be required for the transport
of
only EsxA and perhaps a few other unidentified proteins. If
so, EsaC
would be dispensable for an active ESAT-6 pathway and
might be
specifically involved in the export of EsxB. Alternatively,
the ESAT-6
pathway could be inactive in the
S. aureus MRSA252
strain due
to the absence of EsaC.
Lysis
Various studies have shown that certain proteins with typical
cytoplasmic
functions and without known signals for protein secretion
can
nevertheless be detected in the extracellular proteomes of
different
bacteria
(
174). Notably, many of
these proteins, such as catalase,
elongation factor G, enolase,
glyceraldehyde-3-phosphate dehydrogenase,
GroEL, and superoxide
dismutase, are among the most highly abundant
cytoplasmic proteins.
This makes it likely that they are detectable
in the extracellular
proteome due to cell lysis. Perhaps such
proteins are more resistant to
extracytoplasmic degradation
than are other proteins that are
simultaneously released by
lysis. However, the possibility that the
extracellular localization
of typical cytoplasmic proteins is due to
the activity of as
yet unidentified export pathways cannot be excluded.
Clearly,
until recently this possibility did still apply for the EsxA
and
EsxB proteins, which are now known to be exported via the ESAT-6
pathway.
A clear indication that the presence of certain
"cytoplasmic"
proteins in the extracytoplasmic milieu
of bacteria may relate
to specific export processes was provided by
Boël and coworkers
(
19),
who showed that
2-phosphoglycerate-dependent automodification
of enolase is necessary
for its export from the
cytoplasm.

PROPERTIES OF STAPHYLOCOCCAL SIGNAL PEPTIDES AND CELL RETENTION SIGNALS
Signal Peptides
All proteins that have to be
transported from the cytoplasm
across the membrane to the
extracytoplasmic compartments of
the cell, or the extracellular milieu,
need to contain a specific
sorting signal for their distinction from
resident proteins
of the cytoplasm. The known bacterial sorting signals
for protein
export from the cytoplasm are signal peptides
(
195). These signal
peptides
can be classified by the transport and modification pathways
into
which they direct proteins. Presently, four different bacterial
signal
peptides are recognized that share a common architecture but
differ
in the details (Fig.
5). Two of these direct proteins into the
widely used Sec pathway,
including the secretory (Sec-type)
signal peptides and the lipoprotein
signal peptides. Proteins
with Sec-type or lipoprotein signal peptides
are processed by
different SPases (type I and type II SPases,
respectively) and
are targeted to different destinations. In
S.
aureus, proteins
with Sec-type signal peptides are processed by
the type I SPase
SpsB and are targeted to the cell wall or
extracellular milieu.
Proteins with a lipoprotein signal peptide are
lipid modified
by Lgt prior to being processed by the type II SPase
LspA. In
principle, these lipoproteins are retained at the
membrane-cell
wall interface, but they can be liberated from this
compartment
by proteolytic removal of the N-terminal Cys that contains
the
diacylglyceryl moiety
(
3). Proteins with
twin-arginine (RR)
signal peptides appear to be processed by type I
SPases, at
least in
B. subtilis, and are targeted to the cell
wall or extracellular
milieu
(
174). Proteins with a
pseudopilin signal peptide are
processed by the
pseudopilin signal peptidase ComC and most
likely
are localized to the cytoplasmic membrane and the cell
wall. Finally,
bacteriocins contain a completely different sorting
and modification
signal that is usually called the leader peptide.
The known leader
peptides show no resemblance to the aforementioned
signal peptides. The
export of bacteriocins via ABC transporters
results in their secretion
into the extracellular milieu
(
121,
164).
Sec-type,
lipoprotein, and RR signal peptides contain three
distinguishable
domains, the N, H, and C domains. The N-terminal
domain contains
positively charged amino acids, which are thought
to interact with the
secretion machinery and/or negatively charged
phospholipids in the
membrane. The H domain is formed by a stretch
of hydrophobic amino
acids which facilitate membrane insertion.
Helix-breaking residues in
the middle of the H domain may facilitate
H domain looping during
membrane insertion and translocation
of the precursor protein. The
subsequent unlooping of the H
domain would display the SPase
recognition and cleavage site
at the extracytoplasmic membrane surface,
where the catalytic
domains of type I and type II SPases are localized
(
187). Helix-breaking
residues
just before the SPase recognition and cleavage site would
facilitate
precursor processing by SPase I or II. In fact, these
helix-breaking
residues and the SPase cleavage site, respectively,
define the
beginning and the end of the C domain. Notably, the C
domains
of pseudopilin signal peptides are located between the N and
H
domains (
32,
33,
106,
148). Accordingly,
processing by pseudopilin-specific
SPases, such as ComC, takes place at
the cytoplasmic side of
the membrane and leaves the H domain attached
to the translocated
protein.
While many proteins that end up in
the extracellular milieu or the cell walls of gram-positive bacteria
have signal peptides, proteins without known export signals can also be
found at these locations. The relative number of proteins without known
signal peptides seems to vary for each organism. While these numbers
are relatively low for B. subtilis and S. aureus,
they are high for group A streptococcus and M. tuberculosis
(174). As indicated
above, some of the proteins without known export signals appear to be
liberated from the cell by lysis, while others are actively exported,
for example, via the ESAT-6 pathway. Although the precise export signal
in proteins secreted via the ESAT-6 pathway has not yet been defined, a
WXG motif is shared by these proteins and may serve a function in
protein targeting (140).
Furthermore, the signal for specific release of lysins via holins is
presently not known.
Signal Peptide Predictions
Several prediction programs that are accessible
through the
World Wide Web are useful tools for predicting whether a
given
protein contains some type of sorting signal or SPase cleavage
site.
The programs that we used in this and other studies were
SignalP-NN
and SignalP-HMM, version 2.0
(
136), LipoP, version
1.0 (
94),
PrediSi
(
76), and Phobius
(
95). These programs were
designed
to identify Sec-type signal peptides, N-terminal membrane
anchors
(Phobius), or lipoprotein signal peptides in gram-negative
bacteria
(LipoP). The TMHMM program, version 2.0
(
41), was used to exclude
proteins
with (predicted) multiple membrane-spanning domains.
Predictions
for proteins containing a signal peptide were performed
with
the SignalP program, using the neural network and hidden Markov
model
algorithms. Version 2.0 of the SignalP program was preferred
above
version 3.0 (
12)
for our signal peptide predictions for
S. aureus and
S.
epidermidis because the best overall prediction accuracy
was
obtained with version 2.0 in a recent proteomics-based verification
of
predicted export and retention signals in
B. subtilis
(
179).
Specifically, the
hidden Markov model in SignalP 2.0 assigns
a probability score to each
amino acid of a potential signal
peptide and indicates whether it is
likely to belong to the
N, H, or C domain. Proteins with no detectable
N, H, or C domain
were excluded from the set. Searching for
transmembrane domains
was performed with the TMHMM program, and
proteins with more
than one (predicted) transmembrane domain were
excluded from
the set because they most likely are integral membrane
proteins.
All proteins with a predicted C-terminal transmembrane
segment
in addition to a signal peptide were screened for the presence
of
a conserved motif for covalent cell wall binding. It should
be noted
that this approach does not automatically result in
the exclusion of
potential membrane proteins with one N-terminal
transmembrane domain.
The LipoP program was used to predict
lipoproteins. The combined
results of all these programs resulted
in a list of proteins which have
(i) signal peptides with distinctive
N, H, and C domains, (ii) no
additional transmembrane domains,
and (iii) predicted extracytoplasmic
localizations. These proteins
were scanned for the presence of
proteomics-based consensus
motifs for type I, type II, or
pseudopilin-specific SPase recognition
and cleavage sites,
twin-arginine motifs, and known leader peptides
of bacteriocins by
BLAST searches and by use of the PATTINPROT
program
(
http://npsa-pbil.ibcp.fr),
as previously described
(
179).
To define the
core exoproteome and variant exoproteome of the
S. aureus
strains, the sets of proteins with predicted signal
peptides were used
in multiple BLAST searches with the freeware
BLASTall from the NCBI.
The output was then filtered using Genome2D
(
10).
Secretory (Sec-type) signal peptides.
Proteomics-based data sets of membrane, cell wall,
and extracellular proteins were extremely valuable for a recent
verification of signal peptide predictions for B. subtilis
(179). Such data sets
are now becoming available for S. aureus, as exemplified by
studies on the membrane and cell wall proteomes of S. aureus
Phillips (127) and the
extracellular proteomes of S. aureus strains derived from the
recently sequenced NCTC8325 and COL strains
(208,
209) (Fig.
2). Additionally, the
extracellular proteomes of several clinical S. aureus isolates
have been analyzed (Fig.
2). The membrane, cell
wall, and extracellular proteins of S. aureus that have been
identified by proteomics, involving 2D-PAGE and subsequent
mass spectrometry, are listed
in Tables
4 and
5.These tables also show the 3-to-+1 amino acid
sequences of the respective signal peptidase cleavage sites, if
present.
View this table:
[in this window]
[in a new window]
|
TABLE 5. Identified
proteins in extracellular proteomes of various S. aureus
strains without known signal peptides
|
Based on the proteomics data for membrane and
extracellular
proteins of
B. subtilis, the optimized
3-to-+1 pattern
(AVSTI)-(SEKYHQFLDGPW)-A-(AQVEKDFHLNS)
for signal peptide recognition
and cleavage by type I SPases of this
organism was identified
(
179).
SPase cleavage
occurs C-terminal of the invariant Ala residue
at the 1
position. The residues in parentheses in the
pattern are listed in the
order of frequency, with the most
frequently identified residue at each
position being placed
in the first position. By comparing the predicted
SPase recognition
and cleavage sites for signal peptides of
proteomically identified
extracellular proteins of
S. aureus
(Table
4), we defined the
3-to-+1
pattern (AVS)-(KHNDQSYEGLR)-A-(AESDIKL) for
productive recognition
and cleavage by the type I SPase SpsB. Compared
to the equivalent
pattern in
B. subtilis, it is interesting
that the frequencies
of certain residues at the 3, 2,
and +1 positions
differ, as reflected by the order of frequency
with which they
are listed in the pattern. Moreover, Asn can be present
at the
2 position, while Ile is accepted at the +1
position.
These residues are found at the 2 and +1
positions of
certain serine proteases, hemolysins, immunoglobulin G
(IgG)
binding protein A, and aureolysin (Table
4). It should also
be
noted that compared to the optimized SPase recognition pattern
in
B. subtilis, several residues are not found at the 3,
2,
and +1 positions of potential SpsB recognition and
cleavage
sites in identified extracellular proteins of
S.
aureus. Since
such residues may be present in SPase recognition
and cleavage
sites of proteins that have escaped identification through
proteomics,
we included them in the 3-to-+1 search
pattern (shown
in lowercase) for the identification of potential
secretory
proteins of staphylococci, as follows:
(AVSit)-(KHNDQSYEGLRfpw)-A-(AESDIKLfhnqv).
This optimized
S.
aureus search pattern was used as an indicator
of the quality of
signal peptide predictions based on the SignalP-NN,
SignalP-HMM,
LipoP, PrediSi, Phobius, and TMHMM
programs. Proteins with potential
signal peptides containing this
pattern were assigned to have
a high probability of extracytoplasmic
localization and a low
probability of membrane retention (Tables
6
and
7).Proteins
with potential signal peptides that do not contain this
pattern
were assigned to have a high probability of being retained in
the
membrane (data not shown). In this case, the uncleaved signal
peptide
could serve as an N-terminal membrane anchor. Following this
approach,
sets of 186 to 211 proteins (depending on the
S. aureus strain)
were identified that contain a
potential signal peptide or N-terminal
transmembrane
segment. Scanning for the presence
of the SpsB recognition and
cleavage motif
[(AVSit)-(KHNDQSYEGLRfpw)-A-(AESDIKLfhnqv)]
revealed
that, depending on the
S. aureus strain investigated,
78 to
93 proteins carry this motif. These proteins are most likely
processed
by SPase, liberated from the membrane, and secreted into the
extracellular
milieu, unless they contain a cell wall retention signal
(see
below). Most of the other proteins with signal peptides that
do
not conform to the SpsB recognition and cleavage motif lack
the
invariant Ala at the 1 position. Also, some of these
preproteins
contain different residues at the 3, 2,
or +1
position. For example, Asp, Glu, Phe, and Lys are highly
unlikely
residues at the 3 position
(
187). On the other
hand,
some preproteins have a Gly (e.g., exotoxins 4 and 5 from
S.
aureus COL) or a Leu at the 3 position (Tables
6 and
7). Since
Gly and Leu
residues at the 3 position of signal peptides
are accepted by
the
E. coli SPase, it seems likely that they
are also accepted
at this position by SpsB. However, we did
not include these residues in
the current SpsB recognition and
cleavage motif, since we could neither
identify these proteins
among the secreted proteins of
S.
aureus COL (Fig.
2)
nor find
published evidence that these proteins are indeed secreted.
Among
the proteins with predicted cleavable Sec-type signal peptides,
there
are many known extracellular staphylococcal virulence factors,
such
as exotoxins, enterotoxins (SEM, SEN, and SEO), hemolysins,
TSST-1,
leukotoxins (LukD and LukE), a secretory antigen SsaA
homologue,
and immunodominant antigen A (IsaA). Remarkably, the lists
of
identified extracellular proteins of
S. aureus COL and
RN6390
(
208) (Tables
4 and
5) reveal that about 48%
of these proteins
lack known signal peptides. This percentage is
substantially
higher than the initial estimate of 10%, which was based
on
a limited proteomics-derived data set
(
174). It is also
interesting
that the list of identified extracellular proteins without
a
signal peptide includes enolase, which may be actively exported
by an
unknown mechanism (
19),
but lacks EsxA and EsxB, which
are exported by the ESAT-6 system
(
26).
View this table:
[in this window]
[in a new window]
|
TABLE 6. The core exoproteome of S. aureus, defined as proteins with
predicted Sec-type signal peptides present in all sequenced strainsl
|
View this table:
[in this window]
[in a new window]
|
TABLE 7. Variant
exoproteome of S. aureus, defined as proteins with predicted
Sec-type signal peptides present in at least one sequenced
strain
|
Twin-arginine (RR) signal peptides.
The consensus RR
motif that directs proteins into the Tat pathway
has previously been
defined as (KR)-R-X-#-#, where # is a hydrophobic
residue
(
39,
89). Dilks et al.
(
47) used a genomic
approach
to identify possible Tat substrates for 84 diverse
prokaryotes,
using the TATFIND 1.2 program. Their study included
S.
aureus Mu50, MW2, and N315. Two potential Tat substrates of
unknown
function were predicted for
S. aureus Mu50 and MW2,
and one
of these was also predicted for
S. aureus N315
(
47). However,
both
proteins are conserved in all sequenced
S. aureus strains,
including
the N315 strain. One of the two predicted Tat substrates has
no
known function, whereas the other was annotated as a hypothetical
protein
similar to a ferrichrome ABC transporter (permease).
These proteins,
however, are not in our list of proteins that have a
predicted
RR signal peptide. Although they have signal peptides
according
to the SignalP program, these proteins are
localized in the
cytoplasm or membrane according to the LipoP,
PrediSi, and Phobius
programs. It is therefore unlikely that
these proteins are destined
for secretion. Specifically, the
hypothetical permease has eight
predicted transmembrane
helices.
Our own pattern searches for proteins with a possible RR
motif resulted in 24 to 32 positive hits, depending on the S.
aureus strain investigated. However, most of these proteins have
no detectable N, H, or C domain and were therefore discarded from our
data set. Also, some other proteins with a possible RR motif are
predicted to contain a lipoprotein signal peptide. These predicted
lipoproteins were also discarded from the list of potential S.
aureus Tat substrates, firstly because none of the identified
lipoproteins of B. subtilis that have an RR motif were shown
to be secreted via the Tat pathway
(87,
89) and secondly because
there is no published evidence for any other bacterium that
lipoproteins can be exported Tat dependently. Thus, it appears that
only four or five proteins, depending on the S. aureus strain
investigated, are potentially exported by the Tat pathway and cleaved
by SpsB. However, it is noteworthy that none of the B.
subtilis proteins with a KR motif were secreted Tat dependently,
even though KR motifs are capable of directing proteins into the Tat
pathways of chloroplasts and gram-negative bacteria, such as E.
coli and Salmonella enterica
(77,
82,
123,
167). If KR motifs are
also rejected by the S. aureus Tat pathway, there would not be
a single protein in any sequenced S. aureus strain that is
secreted Tat dependently. This would be highly remarkable in view of
the presence of tatA and tatC genes in all of these
strains. Notably, the only known strictly Tat-dependent extracellular
proteins of B. subtilis are the phosphodiesterase PhoD
(175) and a protein of
unknown function, YwbN
(88). While a homologue
of PhoD is not present in any of the six sequenced S. aureus
strains, homologues of YwbN are present in all of these strains. Close
inspection of the YwbN homologues of S. aureus COL, MRSA252,
and MSSA476 revealed the presence of an N-terminal RR motif, but a
potential signal peptide was not identified as such by the SignalP
program. In contrast, the YwbN homologues of S. aureus Mu50,
MW2, and N315 appear to lack this RR motif. According to comparisons of
the deduced amino acid sequences, these three YwbN homologues should be
missing the first 40 residues of B. subtilis YwbN. This is
most likely not the case, since the sequences upstream of the annotated
S. aureus Mu50, MW2, and N315 ywbN genes encode a
peptide with an RR motif in the same open reading frame as the
ywbN structural gene (Table
6). Thus, the RR motifs of
the S. aureus Mu30, MW2, and N315 YwbN proteins have so far
escaped identification due to a systematic difference in sequence
annotation. It remains to be investigated whether these sequences with
RR motifs serve as signal peptides in the Tat-dependent export of
S. aureus YwbN
homologues.
Pseudopilin signal peptides.
The signal peptides of
pseudopilins differ from the Sec-type signal peptides in the location
of SPase cleavage sites. In pseudopilin signal peptides, the cleavage
site is located between the N and H domains
(105). The consensus
recognition and cleavage motif for pseudopilin SPases, such
as ComC, is K-G-F-X-X-X-E. Cleavage by pseudopilinSPases occurs within this motif, between the Gly and Phe residues. Upon
cleavage, the Phe residue is methylated. For all sequenced S.
aureus strains, three proteins were found to have the canonical
pseudopilin SPase recognition and cleavage motif. These proteins are
homologues of the cold shock proteins CspB, CspC, and CspD of B.
subtilis. However, even though these proteins do contain the
pseudopilin SPase recognition and cleavage pattern, they lack the H
domain. Since the active sites of pseudopilin SPases are located in the
cytoplasm, cleavage of the CspBCD homologues of S. aureus
would be possible, but their export via the Com pathway is unlikely.
Nevertheless, it should be noted that one of the CspBCD homologues of
S. aureus, known as CspA, was found in the extracellular
proteome of a clinical isolate (Fig.
2 and Table
5). To verify the absence
or presence of pseudopilins in S. aureus, BLAST searches with
the known ComGC, ComGD, ComGE, and ComGG proteins of B.
subtilis were performed. This revealed the presence of only one
potential pseudopilin, which is a homologue of B. subtilis
ComGC. Although the consensus pseudopilin SPase recognition and
cleavage site is absent from S. aureus ComGC, a putative
cleavage pattern (Q-A-F-T-L-I-E) is present at the position in the
ComGC signal peptide where a pseudopilin SPase recognition and cleavage
site would be expected. Further analyses revealed that similar
observations can be made for ComGC homologues in other gram-positive
bacteria, such as Bacillus cereus, B. anthracis,
L. monocytogenes, S. haemolyticus, and
Oceanobacillus iheyensis. By comparing the ComGC homologues of
these organisms, an expanded search pattern for gram-positive bacterial
pseudopilin SPase recognition and cleavage sites was defined
as follows: (KEQRS)-(GA)-F-X-X-X-E. Interestingly, using this expanded
search pattern, two additional potential pseudopilins of S.
aureus were identified. These potential pseudopilins show
similarity to the ComGD proteins of B. cereus and B.
anthracis and the ComGF proteins of Bacillus halodurans
and L. lactis. It remains to be shown whether the three
identified potential pseudopilins of S. aureus are indeed able
to assemble into pilin-like structures after being processed by the
ComC homologue. If so, it will be even more interesting to identify
their biological function, for example, in adhesion to surfaces,
motility, or export of proteins. Such functions could play a role in
virulence and have been attributed to type IV pili and
pseudopilins of gram-negative bacteria
(106).
Bacteriocin leader peptides.
Bacteriocins form a
distinct group of proteins with cleavable N-terminal signal peptides,
which are often called leader peptides. These leader peptides only have
N and C domains and completely lack the hydrophobic H domain. The
bacteriocin leader peptides are invoked in posttranslational
modification and the prevention of premature antimicrobial activity,
which would be deleterious to the producing organism. Of the sequenced
S. aureus bacteriocins, C55
and C55ß contain
a leader peptide (130),
whereas leader peptides are absent from aureocin A53
(134) and aureocin A70
(134). Two potential
lantibiotics with leader peptides were identified by sequencing the
genomes of S. aureus MW2
(7) (GI numbers 49486642
and 49486641) and MSSA476. In both strains, the corresponding genes are
located on the genomic island
SAß. Both S.
aureus proteins show similarity to the lantibiotic gallidermin
precursor GdmA of Staphylococcus gallinarum and to the
lantibiotic epidermin precursor EpiA of S. epidermidis.
Notably, the S. aureus COL strain contains only one of these
two potential lantibiotics, which is most similar to the potential MW2
lantibiotic under GI number 49486641. Two additional putative
bacteriocins that were identified by genome sequencing seem to be
homologous to L. lactis lactococcin 972. The hypothetical
protein SAP019 (N315 annotation) is plasmid encoded in S.
aureus N315 and MSSA476 and chromosomally encoded in S.
aureus MRSA252. The other hypothetical bacteriocin, SAS029, is
chromosomally encoded in all sequenced S. aureus strains. No
published data are presently available on the characteristics of these
proteins, so it remains to be seen whether they are genuine
bacteriocins.
Potential ESAT-6 export signal.
As described above, the EsxA and
EsxB proteins are secreted by S. aureus via the ESAT-6 route
(26). Both proteins lack
a known signal peptide but are specifically transported across the
membrane nonetheless. This implies that these two proteins must contain
an export signal that is recognized by one or more ESAT-6 pathway
components. The nature of this signal is presently unknown. The only
common feature of proteins that are known (or predicted) to be
translocated across the membrane via the ESAT-6 pathway is a WXG motif,
which is located
100 amino acids from the N terminus of the
protein (140). The
involvement of the WXG motif in ESAT-6 targeting remains to be
demonstrated.
Retention Signals
Lipoproteins.
Lipoproteins appear to be exported via the Sec
pathway. During
or shortly after translocation, the invariant Cys in
the lipobox
is diacylglyceryl modified by Lgt. This results in signal
peptide
cleavage by SPase II and retention of the mature lipoprotein
in
the membrane. Based on the cleavage sites of lipoproteins
that have
been identified in various gram-positive bacteria,
Sutcliffe and
Harrington (
171)
reported the 4-to-+2 lipobox
pattern
(LIVMFESTAG)-(LVIAMGT)-(IVMSTAFG)-(AG)-C-(SGANERQTL).
Furthermore,
they reported that neither the charged residues Asp, Glu,
Arg,
and Lys nor Gln is present in the region between 6 and 20 residues
N-terminal
of the lipobox. A search of the translated proteins encoded
by
the six
S. aureus genomes with the pattern shown above,
using
the PATTINPROT program, revealed about 50 proteins with this
motif
(Tables
8
and
9). A
comparison of the PATTINPROT results to
the results obtained with the
LipoP program showed that 10 to
16 more potential lipoproteins may be
present in
S. aureus.
Most of these extra predicted
lipoproteins contain an amino
acid at the 1 position (mostly
Ser) or the +2 position
(mostly Asp) that differs from the
lipobox pattern reported
by Sutcliffe and Harrington
(
171). Recently, Tjalsma
and van
Dijl (
179)
proposed the lipobox search pattern
(LITAGMV)-(ASGTIMVF)-(AG)-C-(SGENTAQR)
for potential lipoproteins of
B. subtilis on the basis of published
proteomics data. The
only difference compared to the pattern
by Sutcliffe and Harrington
(
171) is that Leu is
absent from
the +2 position, which is due to the fact that no
potential
B. subtilis lipoprotein with Leu at this position
was identified
by proteomics. Consistently, none of the
predicted
S. aureus lipoproteins has a Leu at the +2
position (Tables
8 and
9).
It is also noteworthy
that some lipoproteins contain a (KR)-R-X-#-#
motif in their signal
peptides, although it has not been shown
yet that lipoproteins can be
transported via the Tat pathway.
Finally, the hypothetical protein Lpl2
of
S. aureus N315 and
Mu50 was excluded from our lipoprotein
predictions because Asp
does not seem to occur at the +2
position of lipoproteins from
gram-positive bacteria
(
94,
179). Nevertheless, the
homologues
of Lpl2 of the other sequenced
S. aureus strains
are classified
as lipoproteins because they have residues at the
+2 position
that conform to the lipobox
consensus.
View this table:
[in this window]
[in a new window]
|
TABLE 8. Core
lipoproteome of S. aureus, defined as proteins with predicted
lipoprotein signal peptides present in all sequenced strains
|
View this table:
[in this window]
[in a new window]
|
TABLE 9. Variant
lipoproteome of S. aureus, defined as proteins with predicted
lipoprotein signal peptides present in at least one sequenced
strain
|
Lipoprotein release determinant.
Although lipoproteins were
generally believed to be retained
at the membrane-cell wall interface,
the presence of lipoproteins
in the growth medium of
B.
subtilis was documented by Antelmann
et al.
(
3). This unexpected
finding was correlated with the
proteolytic removal of the
amino-terminal, lipid-modified Cys,
which suggests that the observed
lipoprotein release into the
growth medium was caused by proteolytic
"shaving" after processing
by LspA. In most of these
lipoproteins, Tjalsma and van Dijl
(
179)
identified the
+1-to-+10 consensus sequence
C-G-(NSTF)-X-(SGN)-X-(SGKAE)-X-X-(SGA),
which might represent the
recognition site for an as yet unidentified
shaving protease. Most
probably, a Gly at the +2 position is
of major importance for
lipoprotein release into the growth
medium, while a Ser at this
position seems to inhibit the process.
In the sequenced genomes of
S. aureus, a gene for only one lipoprotein
with the exact
motif described above could be found. By searching
for patterns with
80% similarity to the consensus sequence (i.e.,
one different residue),
five to seven additional lipoproteins
could be found, depending on the
S. aureus strain. Thr was not
found at the +3 position
in any of these proteins. Instead,
a Lys was identified at this
position in one or two predicted
lipoproteins with a potential release
motif, depending on the
S. aureus strain. In other predicted
lipoproteins with a potential
release motif, no Gly or Ala residue was
found at the +7 position.
However, one of these lipoproteins
contains a predicted release
motif with a Gln at the +7
position. To date, a total of four
potential lipoproteins have been
identified in the extracellular
milieu of
S. aureus. The first
one was identified by Ziebandt
et al.
(
208). This protein was
annotated as a thioredoxin reductase
(Table
4), but it shows no
similarity to known thioredoxin reductases.
Instead, it is highly
similar to phosphate-binding lipoproteins,
such as PstS of
B.
subtilis. It should be noted that this protein
was not
predicted to be a lipoprotein because the signal peptide
contains a Gln
residue in the N domain. According to the search
profile of Sutcliffe
and Harrington(
171), lipoproteins do
not
contain a Gln residue at this position. On the other hand, PstS
of
B. subtilis is a lipoprotein, and it would seem quite likely
that
this is also true for its
S. aureus homologue. The other
three
potential lipoproteins were identified in the growth media of
clinical
isolates (Table
4). Remarkably, none of
the four lipoproteins
with extracellular localization contain the
complete lipoprotein
release motif that was identified in extracellular
lipoproteins
of
B. subtilis. However, they do
contain a Gly residue at the
+2 position, which strengthens the
idea that this amino acid
residue is probably important for lipoprotein
release. It is
interesting that in lipoproteins of gram-negative
bacteria,
an Asp, Gly, Phe, or Trp residue at the +2 position
prevents
transport of the mature lipoprotein to the outer membrane
(
128,
181).
In gram-positive
bacteria, no outer membrane is present, and
it is currently not known
whether the residue at the +2 position
has a role in
subcellular protein sorting. However, a Gly at
this position does seem
to promote lipoprotein release into
the extracellular milieu, not only
in
B. subtilis but also in
S.
aureus.
Cell wall binding domains.
Proteins that have to be
displayed on the bacterial surface must be retained by noncovalent or
covalent binding to the peptidoglycan moiety of the cell wall. In
B. subtilis, several proteins involved in cell wall turnover
contain repeated domains in the C-terminal part of the protein which
have affinity for cell wall components
(62,
110,
150). Specifically, the
B. subtilis proteins LytD, WapA, YocH, YvcE, and YwtD have
been reported to bind to the cell wall
(62,
110,
150). While WapA is not
conserved in staphylococci, various S. aureus proteins with
regions that show amino acid sequence similarity to LytD, YocH, YvcE,
and YwtD of B. subtilis can be found by BLAST searches.
Accordingly, these S. aureus proteins may be cell wall bound,
but this remains to be shown.
One of the domains that have
affinity for cell wall components is the "lysin motif,"
or LysM domain, which was first described for bacterial lysins
(146). The number of
LysM domains can differ for wall-bound proteins from different
gram-positive bacterial species
(168). For example, XlyA
of B. subtilis contains only one LysM domain, whereas three
domains can be detected in AcmA of L. lactis and five or six
domains can be detected in muramidases from Enterococcus
species (92). Using the
LysM domain of AcmA from L. lactis in BLAST searches against
the six sequenced and annotated S. aureus genomes, four
proteins with one or more LysM domains were detected. These proteins
include a hypothetical protein similar to autolysins (SA0423), a
secretory antigen SsaA homologue (SA0620), a conserved
hypothetical protein (SA0710), and the LytN protein.
A different
domain that can facilitate protein binding to the cell wall is the GW
domain. In L. monocytogenes, the surface-exposed InlB protein
contains three C-terminal GW domains. Each domain consists of
80 amino acids and starts with a Gly and a Trp residue
(22). This domain
specifically binds to lipoteichoic acids in the cell wall
(91), thereby
facilitating the interaction of L. monocytogenes with
components of human host cells. The only protein with GW domains found
in the sequenced S. aureus strains is the autolysin protein
Atl (5,
6). This bifunctional
autolysin contains three GW repeats of
97 amino acids. The
protein is exported as a prepro-Atl precursor of 1,256 amino acids.
Subsequent processing steps result in the removal of the signal peptide
and the propeptide and the separation of the mature region into an
amidase and a glucosaminidase
(139). A similar
separation of the mature region into an amidase and glucosaminidase has
been reported for the AtlE protein of S. epidermidis
(74). The GW repeats are
both necessary and sufficient to direct reporter proteins to the
equatorial surface rings of S. aureus cells, where cell
division starts.
Other S. aureus wall proteins that
contain repeated domains with potential wall binding properties have
been described. These include the clumping factors A and B (ClfAB)
(70,
135), several
serine-aspartate repeat proteins (SdrCDE)
(93), the homologue of
S. gordonii GspB (SasA)
(165) (see
"Covalent attachment to the cell wall" below), and an
extracellular matrix-binding protein homologue
(34). Although not
documented in the literature, additional proteins with Sec-type signal
peptides and potential cell wall binding repeats can be recognized
readily. These are the cell wall surface anchor family protein
SACOL2505 and the methicillin-resistant surface protein SACOL0050,
which both contain C-terminal repeat regions of
130 amino
acids. The latter protein, which shows a high degree of sequence
similarity to the SACOL2505 protein, is found only in S.
aureus COL, not in the five other sequenced strains. This is due
to the fact that the gene for SACOL0050 is localized on mec
cassette 1 and therefore not present in the other strains. Notably, the
SACOL2505 homologues in S. aureus Mu50 and N315 seem to lack
the C-terminal part of the protein with the repeats. A close inspection
of the sequences of the corresponding genes in these strains revealed
that there is a frameshift mutation or sequencing error in these genes,
resulting in an apparent or real C-terminal truncation of the
corresponding proteins. Thus, the C-terminal cell wall binding repeats
are absent or appear to be absent. Interestingly, most of the
aforementioned proteins with cell wall binding motifs also contain the
motif LPXTG for covalent attachment to the cell wall by sortase A or
sortase B (see below).
It should be noted that a variety of known
cell wall binding domains, such as the choline binding domain
(205), the Cpl-7 cell
wall binding domain (59),
and the fructosyltransferase cell wall binding domain
(81,
122,
151), appear to be
absent from staphylococcal
proteins.
Covalent attachment to the cell wall.
Cell wall sorting proteins, known as
sortases, exist in many gram-positive bacteria and serve to anchor
proteins that are destined for cell surface display to the cell wall
(50,
182). In almost all
gram-positive bacteria, there is at least one sortase present, and
often genes for more than one sortase-like protein can be detected in a
single genome. These transpeptidases catalyze the formation of an amide
bond between the carboxyl group of a Thr and the free amino end of
pentaglycine cross bridges in peptidoglycan precursors. Subsequently,
the peptidoglycan precursors with covalently bound proteins are
incorporated into the cell wall. More recently, it was shown that
sortases can also be involved in protein polymerization, leading to the
assembly of pili on the surfaces of gram-positive bacteria, such as
Corynebacterium diphtheriae
(61,
182). The
three-dimensional structure of sortase A (SrtA) of
S. aureus revealed that this protein has a unique
ß-barrel structure in which a catalytic Cys residue is
positioned close to a His residue. This suggests that sortase A forms a
thiolate-imidazolium ion pair for catalysis
(83,
183). Furthermore, it
has been shown that a conserved Arg residue is needed for efficient
catalysis (112). The
catalytic cysteine is part of a conserved motif, TLXTC, which can be
found in the C-terminal part of the protein (X is usually Val, Thr, or
Ile). Recently, a classification of sortases was proposed by Dramsi et
al. (50), based on
phylogenetic analyses of 61 sortases that are encoded by the genomes of
22 gram-positive bacteria. These analyses showed that sortases can be
grouped into four different classes (A to D). Class A consists of
sortases from many low-GC% gram-positive bacteria, including L.
monocytogenes, Streptococcus pyogenes, and
S. aureus. The second class (class B) is present in only a few
low-GC% gram-positive bacteria, including L.
monocytogenes, B. anthracis, and S.
aureus. Sortases of this class contain three amino acid
segments that are not present in the sortases of class A. These
sortases recognize a different motif (NPQTN in S. aureus). The
genes for substrates of class B sortases are often found at the same
locus as the sortase gene. The largest class (class C) consists of
sortases from high-GC% and low-GC% gram-positive bacteria. The genes
for class C sortases are often present in multiple copies per genome.
The characteristics of this class of sortases include a C-terminal
hydrophobic domain that might serve as a membrane anchor and a
conserved proline residue behind the catalytic site. Finally, class D
sortases are present in high- and low-GC% gram-positive bacteria. This
class can be divided into three subclusters, depending on whether the
sortases are present in bacilli, clostridia, or actinomycetes. Since
class C and D sortases are absent from S. aureus, the
(potential) substrates of these enzymes are not reviewed
here.
(i) Sortase A recognition signal.
For interaction with host cells
during infection, many proteins are anchored to the cell walls of
staphylococcal cells, thereby enabling the cells to adhere to and
invade the host cells or to evade the immune system. Many of these
proteins contain an LPXTG motif in their C-terminal part, which is
recognized by the cell wall sorting protein sortase A. In each of the
six sequenced S. aureus strains, there is only one sortase
gene present, which encodes a class A sortase. The LPXTG motif of
sortase A substrates is followed by a stretch of hydrophobic amino
acids and at least one positively charged amino acid (Lys or Arg) at
the C terminus. After protein translocation across the membrane, the
LPXTG motif is recognized by SrtA and subsequently cleaved between the
Thr and Gly residues
(115,
131). Transpeptidation
is then mediated by SrtA through amide linkage of the C-terminal Thr of
the protein to pentaglycine cross bridges. It has been suggested that
SrtA actually uses lipid II as a peptidoglycan substrate and that the
proteins linked to lipid II are subsequently incorporated into the cell
wall. In addition to the canonical LPXTG motif, an LPXAG motif can also
be recognized and cleaved by SrtA
(156).
It has been
reported that S. aureus has 19 proteins that carry the LPXTG
motif and 2 proteins that carry the LPXAG motif at their C termini
(156). Many of these
proteins have been shown to be expressed. These include protein A
(Spa), two clumping factors (ClfA and ClfB; also contain potential wall
binding repeats), a collagen-binding protein (Cna), three
serine-aspartate repeat proteins (SdrC, SdrD, and SdrE; also contain
potential wall binding repeats), two fibronectin-binding proteins
(FnbpA and FnbpB) (reviewed by Foster and Hook
[58]), a
plasmin-sensitive protein (Pls)
(163), FmtB
(98), and several S.
aureus surface (Sas) proteins
(156). A
recent study on the cell wall and membrane proteome by
Nandakumar et al. (127)
resulted in the identification of two proteins with an LPXTG cell wall
sorting signal. Many of the LPXTG-containing proteins
contain a conserved motif, (YF)-SIRK (with some variance), in their
N-terminal signal peptides, which has also been observed for other
proteins that are substrates for SrtA in several gram-positive bacteria
(9). However, this
sequence is not found in all SrtA substrates and can also be found in
non-cell-wall proteins. This suggests that (YF)-SIRK is not a specific
SrtA targeting sequence. One of the sas genes, sasA,
is situated in the secA2/secY2 cluster and has an
unusually long signal peptide (90 residues), which might indicate that
the accessory SecA2/SecY2 system is needed for the
transport of SasA across the membrane. If so, this
would be similar to the case reported for the cell wall-bound
GspB protein of S. gordonii
(13).
Depending on
the sequenced S. aureus strain, 10 to 13 proteins with an
LPXTG cell wall sorting signal followed by a hydrophobic stretch of
residues and a positively charged C terminus can be found (Table
10). Among these proteins are fibrinogen-binding protein A (ClfA), the
immunoglobulin G binding protein A precursor (Spa), and the
Ser-Asp-rich, fibrinogen-binding bone
sialoprotein-binding protein (SdrC). Five additional proteins (SdrD,
SdrE, SasC, FnbA, and FnbB) with an LPXTG motif can be found among the
S. aureus strains (Table
10). These
five proteins were excluded from our initial list because the
corresponding SignalP scores were lower than our (high) score
criterion. However, since some of the domains present in these proteins
(besides the LPXTG motif) are conserved in well-described cell wall
proteins, they were included in Table
10. The remaining
proteins with a cell wall sorting signal either are missing in one or
more S. aureus strains or have been annotated wrongly.
Interestingly, S. epidermidis ATCC 12228 contains a gene for a
class C sortase (srtC) which seems to be absent from other
staphylococci. This SrtC protein is most closely related to sortases of
L. lactis and Streptococcus suis. Two proteins with
LPXTG motifs which are encoded by the same genomic island as SrtC also
seem to be strain specific
(63).
View this table:
[in this window]
[in a new window]
|
TABLE 10. Staphylococcal
proteins with (potential) Sec-type signal peptides and (potential)
signals for covalent cell wall binding
|
(ii) Sortase B recognition signal.
All
sequenced
S. aureus strains contain sortase B (SrtB) in
addition
to SrtA. The gene for SrtB is situated at a locus which is
involved
in the uptake of heme iron
(
116). This locus also
contains the
gene for the cell wall protein IsdC, which contains the
SrtB
recognition sequence NPQTN. In addition, this locus contains
the
genes for the SrtA substrates IsdA and IsdB, which both
contain LPXTG
motifs. Notably, IsdC is so far the only protein
known to be anchored
to the cell wall by sortase B. IsdC is
cleaved by SrtB between the Thr
and Asn residues of the NPQTN
motif. The only other
S. aureus
protein with a motif that resembles
NPQTN is the DNA-binding protein
II, but this protein is probably
not cell wall bound because it lacks a
signal peptide for export
from the
cytoplasm.

COMPARATIVE SECRETOME ANALYSIS
Comparison of the predicted secretomes of
S. aureus and
S. epidermidis with those of
B.
subtilis and other gram-positive bacteria revealed
that most of
the known components of the translocation machinery
are present in
S. aureus. The most notable differences are the
second set of
secA and
secY genes in
S. aureus, the
absence
of known signal peptide peptidases from
S. aureus and
S. epidermidis,
the absence of a BdbC homologue from
S.
aureus and
S. epidermidis,
the presence of a second
lspA gene in
S. epidermidis, the absence
of a Tat
system from
S. epidermidis, and the absence of two
potential
components in the ESAT-6 pathway from
S. aureus MRSA252
(Table
3). So far, no evidence
has been published on whether
SecA2 and SecY2 are involved in the
export of important virulence
factors in
S. aureus. However,
it has been shown that the second
secA/
secY set is
involved in the export of virulence factors
in other pathogens
(
172). Although most
known determinants for
protein export, processing, and
posttranslocational modification
in other gram-positive bacteria are
also present in
S. aureus,
in many cases it remains to be
investigated to what extent they
are necessary for protein export in
general and the export of
virulence factors in particular.
As
shown by multiple BLAST comparisons, the core exoproteome of the
sequenced S. aureus strains consists of 58 proteins (Table
6). All of these proteins
have a signal peptide with a potential SpsB recognition and cleavage
site. Thirty-three of these core exoproteins have already been
identified in the extracellular milieus and/or membrane/cell wall
proteomes of different S. aureus isolates
(127,
208). Interestingly, 26
core exoproteins of S. aureus are also conserved in S.
epidermidis, suggesting that they belong to a core staphylococcal
exoproteome, which is presently still poorly defined. Interestingly,
the core exoproteome of S. aureus seems to be largely composed
of enzymes, such as proteases, and other factors, such as fibrinogen-
and IgG-binding proteins, that are required for life in the ecological
niches provided by the human host (Table
6). This is particularly
true for the proteins that have the potential to be covalently bound to
the cell wall (Table 10).
In contrast, the variant exoproteome of S. aureus contains
most of the known staphylococcal toxins and immunomodulating factors
(Tables 7 and
11). This suggests that the components of the variant exoproteome should be
regarded as specific gadgets of S. aureus that help this
organism to conquer certain protected niches of the human host, thereby
causing disease. If this idea is correct, then proteins of unknown
function that belong to the variant exoproteome should be regarded as
potentially important virulence factors.
The (predicted)
extracellular toxins of
S. aureus are not present
in
S.
epidermidis. This is mainly due to the fact that these
toxins are
encoded by pathogenicity islands in the genomes of
S. aureus
strains that have thus far not been observed in
S. epidermidis
genomes. Proteins with predicted signal peptides
that are specific for
S. epidermidis are listed in Table
12.
Notably, the majority (i.e., 26 of 30) of predicted
S.
epidermidis exoproteins that have homologues in
S. aureus
share this homology
with components of the core exoproteome of
S.
aureus (Tables
6 and
7). This suggests that in
S. epidermidis, the core exoproteome
is also involved in
housekeeping functions. In contrast to the
case for the exoproteome, it
is presently difficult to speculate
about housekeeping and
disease-causing roles of the constant
and variant lipoproteomes of
S. aureus. This is due to the fact
that the functions of only
a few
S. aureus lipoproteins are
known (Tables
8,
9, and
13). In general terms, it is presently
not clear why
S. epidermidis
seems to export a smaller number
of different proteins (101 in total)
than does
S. aureus (

135
in total). This difference
is all the more remarkable since
the total numbers of proteins encoded
by the genomes of
S. aureus (

2,600) and
S.
epidermidis (

2,500) are comparable.
Compared to
B. subtilis and
B. licheniformis
(
193),
S.
aureus is also predicted to export a relatively large number of
proteins
from the cytoplasm to the membrane-cell wall interface, the
cell
wall, and the extracellular milieu. The genomes of
B.
subtilis and
B. licheniformis contain

4,100
protein-encoding genes, while
S. aureus genomes contain
significantly fewer genes (

2,600).
Using the most recent
prediction protocols
(
179),
B.
subtilis is predicted to export 190 proteins to an
extracytoplasmic location,
whereas, depending on the strain
investigated,
S. aureus is
predicted to export 130 to 145
proteins (this review). Accordingly,
as judged by the relative numbers
of protein-encoding genes,
S. aureus strains appear to export
6 to 20% more proteins to
an extracytoplasmic location than do the
aforementioned bacilli.
Most probably, this is related to the fact that
S. aureus needs
an arsenal of virulence factors, such as
toxins and surface
proteins, for colonization of and survival in its
preferred
niches in the human host. Such proteins are of less
importance
for soil bacteria, such as
B. subtilis and
B.
licheniformis,
which thrive predominantly on dead organic
matter.

PERSPECTIVES
The present
review provides a survey of possible protein transport
pathways in
staphylococcal pathogenesis. In many cases, the
knowledge gathered from
protein secretion studies in other organisms
has been projected on
S. aureus, assuming that similar pathways
or pathway
components have similar functions in different organisms.
Clearly, this
leaves room for surprises when such pathways are
investigated
thoroughly for
S. aureus. The same was true for
studies on
protein secretion in
B. subtilis. These studies showed,
for
example, that the absence of SecDF has barely any consequences
for
protein secretion by
B. subtilis, whereas SecD and SecF
are of
key importance for protein translocation in
E. coli,
the
organism in which SecD/F was first discovered
(
20). Likewise,
LspA was
shown to be dispensable in
B. subtilis but not in
E.
coli (
147,
177). Thus, the relative
importance of different secretion
machinery components of
S.
aureus needs to be assessed in a
systematic manner, preferably in
an isogenic background. Such
studies would need to address the
importance of secretion machinery
components for in vitro growth on
different substrates (e.g.,
broth or blood) and for virulence in vivo
in model systems (e.g.,
C. elegans,
Drosophila
melanogaster, mice, or rats)
(
8,
60,
173).
These studies
should be complemented with proteomic verification
of our present
lipoproteome, wall proteome, and exoproteome
predictions. Such a
verification could involve both gel-based
proteomics approaches, as
outlined in this review, and more
sophisticated gel-free proteomics
approaches (
194). This
would
lead to an improved understanding of the contribution of each
protein
transport pathway and its substrate proteins to staphylococcal
cell
physiology and virulence. Since the virulence of different
S.
aureus strains will depend not only on the presence (or absence)
of
particular genes for virulence factors but also on their expression,
such
proteomic studies should also include experiments on the impacts
of
major regulatory systems, such as
agr,
sae, and
sarA. On this
basis, it should be possible to identify the
most promising
candidate drug targets in the staphylococcal secretome.
Alternatively,
secretome components thus identified could represent
promising
candidates for novel vaccines. For all of these efforts,
comparative
secretomics approaches will provide essential information
on
those potential drug targets that are most important for both
bacterial
housekeeping functions and virulence. Novel drugs and
vaccines
designed against these targets are likely to have the highest
impact
(
65).

ACKNOWLEDGMENTS
We
thank Harold Tjalsma and members of the Groningen and European
Bacillus Secretion Groups and the BACELL Health, Tat Machine,
and StaphDynamics
consortia for stimulating
discussions.
M.J.J.B.S., A.K.Z., S.E., M.H., J.Y.F.D., and
J.M.V.D. were supported by grants LSHG-CT-2004-503468,
LSHG-CT-2004-005257, and LSHM-CT-2006-019064 from the European Union.
M.H. was supported by grants from the Deutsche Forschungsgemeinschaft,
the Bundesministerium für Bildung, Wissenschaft, Forschung und
Technologie, and the Fonds der Chemischen
Industrie.

FOOTNOTES
* Corresponding
author. Mailing address: Department of Medical Microbiology, University
Medical Centre Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB
Groningen, The Netherlands. Phone: 31-50-3633079. Fax: 31-50-3633528.
E-mail:
j.m.van.dijl{at}med.umcg.nl.


REFERENCES
1 - Adhikari, R. P., and
R. P. Novick. 2005. Subinhibitory cerulenin
inhibits staphylococcal exoprotein production by blocking transcription
rather than by blocking secretion. Microbiology
151:3059-3069.[Abstract/Free Full Text]
2 - Alami,
M., I. Lüke, S. Deitermann, G. Eisner, H. G. Koch, J.
Brunner, and M. Müller. 2003. Differential
interactions between a twin-arginine signal peptide and its translocase
in Escherichia coli. Mol. Cell
12:937-946.[CrossRef][Medline]
3 - Antelmann,
H., H. Tjalsma, B. Voigt, S. Ohlmeier, S. Bron, J. M. van
Dijl, and M. Hecker. 2001. A proteomic view on
genome-based signal peptide predictions. Genome Res.
11:1484-1502.[Abstract/Free Full Text]
4 - Avison,
M. B., P. M. Bennett, R. A. Howe, and
T. R. Walsh. 2002. Preliminary analysis of
the genetic basis for vancomycin resistance in Staphylococcus
aureus strain Mu50. J. Antimicrob. Chemother.
49:255-260.[Abstract/Free Full Text]
5 - Baba,
T., and O. Schneewind. 1996. Target cell specificity
of a bacteriocin molecule: a C-terminal signal directs lysostaphin to
the cell wall of Staphylococcus aureus. EMBO J.
15:4789-4797.[Medline]
6 - Baba,
T., and O. Schneewind. 1998. Targeting of muralytic
enzymes to the cell division site of gram-positive bacteria: repeat
domains direct autolysin to the equatorial surface ring of
Staphylococcus aureus. EMBO J.
17:4639-4646.[CrossRef][Medline]
7 - Baba,
T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N.
Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K.
Hiramatsu. 2002. Genome and virulence determinants of
high virulence community-acquired MRSA. Lancet
359:1819-1827.[CrossRef][Medline]
8 - Bae,
T., A. K. Banger, A. Wallace, E. M. Glass, F.
Åslund, O. Schneewind, and D. M. Missiakas.2004
. Staphylococcus aureus virulence genes
identified by bursa aurealis mutagenesis and nematode killing.Proc. Natl. Acad. Sci. USA
101:12312-12317.[Abstract/Free Full Text]
9 - Bae,
T., and O. Schneewind. 2003. The YSIRK-G/S motif of
staphylococcal protein A and its role in efficiency of signal peptide
processing. J. Bacteriol.
185:2910-2919.[Abstract/Free Full Text]
10 - Baerends,
R. J., W. K. Smits, A. de Jong, L. W.
Hamoen, J. Kok, and O. P. Kuipers. 2004.
Genome2D: a visualization tool for the rapid analysis of bacterial
transcriptome data. Genome Biol.
5:R37.[CrossRef][Medline]
11 - Bayles,
K. W. 2000. The bactericidal action of
penicillin: new clues to an unsolved mystery. Trends
Microbiol.
8:274-278.[CrossRef][Medline]
12 - Bendtsen,
J. D., H. Nielsen, G. von Heijne, and S. Brunak.2004
. Improved prediction of signal peptides: SignalP 3.0.J. Mol. Biol.
340:783-795.[CrossRef][Medline]
13 - Bensing,
B. A., and P. M. Sullam. 2002. An
accessory sec locus of Streptococcus gordonii is
required for export of the surface protein GspB and for normal levels
of binding to human platelets. Mol. Microbiol.
44:1081-1094.[CrossRef][Medline]
14 - Berks,
B. C., T. Palmer, and F. Sargent. 2005.
Protein targeting by the bacterial twin-arginine translocation (Tat)
pathway. Curr. Opin. Microbiol.
8:174-181.[CrossRef][Medline]
15 - Bernhardt,
J., K. Büttner, C. Scharf, and M. Hecker. 1999.
Dual channel imaging of two-dimensional electropherograms in
Bacillus subtilis. Electrophoresis
20:2225-2240.[CrossRef][Medline]
16 - Berthet,
F. X., P. B. Rasmussen, I. Rosenkrands, P.
Andersen, and B. Gicquel. 1998. A Mycobacterium
tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass
culture filtrate protein (CFP-10). Microbiology
144:3195-3203.[Abstract]
17 - Bibi,
E. 1998. The role of the ribosome-translocon complex
in translation and assembly of polytopic membrane proteins.Trends Biochem. Sci.
23:51-55.[CrossRef][Medline]
18 - Blaudeck,
N., P. Kreutzenbeck, M. Müller, G. A. Sprenger, and R.
Freudl. 2005. Isolation and characterization of
bifunctional Escherichia coli TatA mutant proteins that allow
efficient tat-dependent protein translocation in the absence
of TatB. J. Biol. Chem.
280:3426-3432.[Abstract/Free Full Text]
19 - Boël,
G., V. Pichereau, I. Mijakovic, A. Mazé, S. Poncet, S. Gillet,
J. C. Giard, A. Hartke, Y. Auffray, and J. Deutscher.2004
. Is 2-phosphoglycerate-dependent automodification of
bacterial enolases implicated in their export? J. Mol.
Biol.
337:485-496.[CrossRef][Medline]
20 - Bolhuis,
A., C. P. Broekhuizen, A. Sorokin, M. L. van
Roosmalen, G. Venema, S. Bron, W. J. Quax, and J.
M. van Dijl. 1998. SecDF of Bacillus
subtilis, a molecular Siamese twin required for the efficient
secretion of proteins. J. Biol. Chem.
273:21217-21224.[Abstract/Free Full Text]
21 - Bolhuis,
A., A. Matzen, H. L. Hyyryläinen, V. P.
Kontinen, R. Meima, J. Chapuis, G. Venema, S. Bron, R.
Freudl, and J. M. van Dijl. 1999. Signal
peptide peptidase- and ClpP-like proteins of Bacillus subtilis
required for efficient translocation and processing of secretory
proteins. J. Biol. Chem.
274:24585-24592.[Abstract/Free Full Text]
22 - Braun,
L., S. Dramsi, P. Dehoux, H. Bierne, G. Lindahl, and P. Cossart.1997
. InlB: an invasion protein of Listeria
monocytogenes with a novel type of surface association.Mol. Microbiol.
25:285-294.[CrossRef][Medline]
23 - Bruton,
G., A. Huxley, P. O'Hanlon, B. Orlek, D. Eggleston, J. Humphries, S.
Readshaw, A. West, S. Ashman, M. Brown, K. Moore, A. Pope, K. O'Dwyer,
and L. Wang. 2003. Lipopeptide substrates for SpsB,
the Staphylococcus aureus type I signal peptidase: design,
conformation and conversion to alpha-ketoamide inhibitors. Eur.
J. Med. Chem.
38:351-356.[CrossRef][Medline]
24 - Bugg,
T. D., G. D. Wright, S. Dutka-Malen, M. Arthur, P.
Courvalin, and C. T. Walsh. 1991. Molecular
basis for vancomycin resistance in Enterococcus faecium
BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by
vancomycin resistance proteins VanH and VanA.Biochemistry
30:10408-10415.[CrossRef][Medline]
25 - Bunai,
K., K. Yamada, K. Hayashi, K. Nakamura, and K. Yamane.1999
. Enhancing effect of Bacillus subtilis Ffh,
a homologue of the SRP54 subunit of the mammalian signal recognition
particle, on the binding of SecA to precursors of secretory proteins
in vitro. J. Biochem. (Tokyo)
125:151-159.[Abstract/Free Full Text]
26 - Burts,
M. L., W. A. Williams, K. DeBord, and D.
M. Missiakas. 2005. EsxA and EsxB are secreted by an
ESAT-6-like system that is required for the pathogenesis of
Staphylococcus aureus infections. Proc. Natl. Acad.
Sci. USA
102:1169-1174.[Abstract/Free Full Text]
27 - Centers
for Disease Control and Prevention. 2003.
Methicillin-resistant Staphylococcus aureus infections in
correctional facilitiesGeorgia, California, and Texas,
2001-2003. Morb. Mortal. Wkly. Rep.
52:992-995.[Medline]
28 - Chambers,
H. F. 1997. Methicillin resistance in
staphylococci: molecular and biochemical basis and clinical
implications. Clin. Microbiol. Rev.
10:781-791.[Abstract]
29 - Cheung,
A. L., J. M. Koomey, C. A. Butler,
S. J. Projan, and V. A. Fischetti.1992
. Regulation of exoprotein expression in
Staphylococcus aureus by a locus (sar) distinct from
agr. Proc. Natl. Acad. Sci. USA
89:6462-6466.[Abstract/Free Full Text]
30 - Cheung,
A. L., and S. J. Projan. 1994.
Cloning and sequencing of sarA of Staphylococcus
aureus, a gene required for the expression of agr.J. Bacteriol.
176:4168-4172.[Abstract/Free Full Text]
31 - Chung,
Y. S., F. Breidt, and D. Dubnau. 1998. Cell
surface localization and processing of the ComG proteins, required for
DNA binding during transformation of Bacillus subtilis.Mol. Microbiol.
29:905-913.[CrossRef][Medline]
32 - Chung,
Y. S., and D. Dubnau. 1998. All seven
comG open reading frames are required for DNA binding during
transformation of competent Bacillus subtilis. J.
Bacteriol.
180:41-45.[Abstract/Free Full Text]
33 - Chung,
Y. S., and D. Dubnau. 1995. ComC is required
for the processing and translocation of comGC, a pilin-like
competence protein of Bacillus subtilis. Mol.
Microbiol.
15:543-551.[CrossRef][Medline]
34 - Clarke,
S. R., L. G. Harris, R. G. Richards, and
S. J. Foster. 2002. Analysis of Ebh, a
1.1-megadalton cell wall-associated fibronectin-binding protein of
Staphylococcus aureus. Infect. Immun.
70:6680-6687.[Abstract/Free Full Text]
35 - Clarke,
S. R., M. D. Wiltshire, and S. J.
Foster. 2004. IsdA of Staphylococcus aureus
is a broad spectrum, iron-regulated adhesin. Mol.
Microbiol.
51:1509-1519.[CrossRef][Medline]
36 - Cline,
K., and H. Mori. 2001. Thylakoid DeltapH-dependent
precursor proteins bind to a cpTatC-Hcf106 complex before
Tha4-dependent transport. J. Cell Biol.
154:719-729.[Abstract/Free Full Text]
37 - Converse,
S. E., and J. S. Cox. 2005. A
protein secretion pathway critical for Mycobacterium
tuberculosis virulence is conserved and functional in
Mycobacterium smegmatis. J. Bacteriol.
187:1238-1245.[Abstract/Free Full Text]
38 - Cregg,
K. M., I. Wilding, and M. T. Black.1996
. Molecular cloning and expression of the
spsB gene encoding an essential type I signal peptidase from
Staphylococcus aureus. J. Bacteriol.
178:5712-5718.[Abstract/Free Full Text]
39 - Cristóbal,
S., J. W. de Gier, H. Nielsen, and G. von Heijne.1999
. Competition between Sec- and Tat-dependent protein
translocation in Escherichia coli. EMBO J.
18:2982-2990.[CrossRef][Medline]
40 - Crupper,
S. S., A. J. Gies, and J. J. Iandolo.1997
. Purification and characterization of staphylococcin
BacR1, a broad-spectrum bacteriocin. Appl. Environ.
Microbiol.
63:4185-4190.[Abstract]
41 - Cserzö,
M., E. Wallin, I. Simon, G. von Heijne, and A. Elofsson.1997
. Prediction of transmembrane alpha-helices in
prokaryotic membrane proteins: the dense alignment surface method.Protein Eng.
10:673-676.[Abstract/Free Full Text]
42 - Cui,
L., X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M.
Mamizuka, C. G. Gemmell, M. N. Kim, M. C.
Ploy, N. El Solh, V. Ferraz, and K. Hiramatsu. 2003.
Cell wall thickening is a common feature of vancomycin resistance in
Staphylococcus aureus. J. Clin.
Microbiol.
41:5-14.[Abstract/Free Full Text]
43 - da
Silva, M. C., J. M. Zahm, D. Gras, O. Bajolet, M.
Abely, J. Hinnrasky, M. Milliot, M. C. de Assis, C. Hologne,
N. Bonnet, M. Merten, M. C. Plotkowski, and E. Puchelle.2004
. Dynamic interaction between airway epithelial cells
and Staphylococcus aureus. Am. J. Physiol.
Lung Cell Mol. Physiol.
287:L543-L551.[Abstract/Free Full Text]
44 - de
Keyzer, J., C. van der Does, and A. J. Driessen.2003
. The bacterial translocase: a dynamic protein channel
complex. Cell. Mol. Life Sci.
60:2034-2052.[CrossRef][Medline]
45 - De
Leeuw, E., K. te Kaat, C. Moser, G. Menestrina, R. Demel, B. de
Kruijff, B. Oudega, J. Luirink, and I. Sinning. 2000.
Anionic phospholipids are involved in membrane association of FtsY and
stimulate its GTPase activity. EMBO J.
19:531-541.[CrossRef][Medline]
46 - Diep,
B. A., S. R. Gill, R. F. Chang,
T. H. Phan, J. H. Chen, M. G. Davidson,
F. Lin, J. Lin, H. A. Carleton, E. F. Mongodin,
G. F. Sensabaugh, and F. Perdreau-Remington.2006
. Complete genome sequence of USA300, an epidemic
clone of community-acquired methicillin-resistant Staphylococcus
aureus. Lancet
367:731-739.[CrossRef][Medline]
47 - Dilks,
K., R. W. Rose, E. Hartmann, and M. Pohlschröder.2003
. Prokaryotic utilization of the twin-arginine
translocation pathway: a genomic survey. J. Bacteriol.
185:1478-1483.[Abstract/Free Full Text]
48 - Dinges,
M. M., P. M. Orwin, and P. M.
Schlievert. 2000. Exotoxins of Staphylococcus
aureus. Clin. Microbiol. Rev.
13:16-34.[Abstract/Free Full Text]
49 - Dobrindt,
U., B. Hochhut, U. Hentschel, and J. Hacker. 2004.
Genomic islands in pathogenic and environmental microorganisms.Nat. Rev. Microbiol.
2:414-424.[CrossRef][Medline]
50 - Dramsi,
S., P. Trieu-Cuot, and H. Bierne. 2005. Sorting
sortases: a nomenclature proposal for the various sortases of
gram-positive bacteria. Res. Microbiol.
156:289-297.[CrossRef][Medline]
51 - Driessen,
A. J., P. Fekkes, and J. P. van der Wolk.1998
. The Sec system. Curr. Opin.
Microbiol.
1:216-222.[CrossRef][Medline]
52 - Dubnau,
D. 1999. DNA uptake in bacteria. Annu. Rev.
Microbiol.
53:217-244.[CrossRef][Medline]
53 - Dumoulin,
A., U. Grauschopf, M. Bischoff, L. Thöny-Meyer, and B.
Berger-Bächi. 2005. Staphylococcus
aureus DsbA is a membrane-bound lipoprotein with thiol-disulfide
oxidoreductase activity. Arch. Microbiol.
184:117-128.[CrossRef][Medline]
54 - Dziewanowska,
K., V. M. Edwards, J. R. Deringer, G. A.
Bohach, and D. J. Guerra. 1996. Comparison
of the beta-toxins from Staphylococcus aureus and
Staphylococcus intermedius. Arch. Biochem.
Biophys.
335:102-108.[CrossRef][Medline]
55 - Eisner,
G., H. G. Koch, K. Beck, J. Brunner, and M. Müller.2003
. Ligand crowding at a nascent signal sequence.J. Cell Biol.
163:35-44.[Abstract/Free Full Text]
56 - Escher,
A., and W. G. Characklis. 1990. Modeling the
initial events in biofilm accumulation, p.445
-486. In W. G.
Characklis (ed.), Biofilms. Wiley Press, New York,
N.Y.
57 - Fedtke,
I., F. Gotz, and A. Peschel. 2004. Bacterial evasion
of innate host defensesthe Staphylococcus aureus
lesson. Int. J. Med. Microbiol.
294:189-194.[CrossRef][Medline]
58 - Foster,
T. J., and M. Hook. 1998. Surface protein
adhesins of Staphylococcus aureus. Trends
Microbiol.
6:484-488.[CrossRef][Medline]
59 - Garcia,
P., J. L. Garcia, E. Garcia, J. M. Sanchez-Puelles,
and R. Lopez. 1990. Modular organization of the lytic
enzymes of Streptococcus pneumoniae and its bacteriophages.Gene
86:81-88.[CrossRef][Medline]
60 - Garcia-Lara,
J., A. J. Needham, and S. J. Foster.2005
. Invertebrates as animal models for
Staphylococcus aureus pathogenesis: a window into
host-pathogen interaction. FEMS Immunol. Med. Microbiol.
43:311-323.[CrossRef][Medline]
61 - Gaspar,
A. H., and H. Ton-That. 2006. Assembly of
distinct pilus structures on the surface of Corynebacterium
diphtheriae. J. Bacteriol.
188:1526-1533.[Abstract/Free Full Text]
62 - Ghuysen,
J. M., J. Lamotte-Brasseur, B. Joris, and G. D.
Shockman. 1994. Binding site-shaped repeated sequences
of bacterial wall peptidoglycan hydrolases. FEBS Lett.
342:23-28.[CrossRef][Medline]
63 - Gill,
S. R., D. E. Fouts, G. L. Archer,
E. F. Mongodin, R. T. Deboy, J. Ravel, I.
T. Paulsen, J. F. Kolonay, L. Brinkac, M. Beanan,
R. J. Dodson, S. C. Daugherty, R. Madupu,
S. V. Angiuoli, A. S. Durkin, D. H. Haft,
J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. Dimitrov, L. Jiang,
H. Qin, J. Weidman, K. Tran, K. Kang, I. R. Hance,
K. E. Nelson, and C. M. Fraser.2005
. Insights on evolution of virulence and resistance
from the complete genome analysis of an early methicillin-resistant
Staphylococcus aureus strain and a biofilm-producing
methicillin-resistant Staphylococcus epidermidis strain.J. Bacteriol.
187:2426-2438.[Abstract/Free Full Text]
64 - Götz,
F. 2002. Staphylococcus and biofilms.Mol. Microbiol.
43:1367-1378.[CrossRef][Medline]
65 - Götz,
F. 2004. Staphylococci in colonization and disease:
prospective targets for drugs and vaccines. Curr. Opin.
Microbiol.
7:477-487.[CrossRef][Medline]
66 - Groicher,
K. H., B. A. Firek, D. F. Fujimoto, and
K. W. Bayles. 2000. The Staphylococcus
aureus lrgAB operon modulates murein hydrolase activity and
penicillin tolerance. J. Bacteriol.
182:1794-1801.[Abstract/Free Full Text]
67 - Grundmann,
H., A. Tami, S. Hori, M. Halwani, and R. Slack. 2002.
Nottingham Staphylococcus aureus population study: prevalence
of MRSA among elderly people in the community. BMJ
324:1365-1366.[Free Full Text]
68 - Grundmeier,
M., M. Hussain, P. Becker, C. Heilmann, G. Peters, and B. Sinha.2004
. Truncation of fibronectin-binding proteins in
Staphylococcus aureus strain Newman leads to deficient
adherence and host cell invasion due to loss of the cell wall anchor
function. Infect. Immun.
72:7155-7163.[Abstract/Free Full Text]
69 - Hahn,
J., B. Maier, B. J. Haijema, M. Sheetz, and D. Dubnau.2005
. Transformation proteins and DNA uptake localize to
the cell poles in Bacillus subtilis. Cell
122:59-71.[CrossRef][Medline]
70 - Hartford,
O., P. Francois, P. Vaudaux, and T. J. Foster.1997
. The dipeptide repeat region of the
fibrinogen-binding protein (clumping factor) is required for functional
expression of the fibrinogen-binding domain on the Staphylococcus
aureus cell surface. Mol. Microbiol.
25:1065-1076.[CrossRef][Medline]
71 - Hasona,
A., P. J. Crowley, C. M. Levesque, R. W.
Mair, D. G. Cvitkovitch, A. S. Bleiweis, and
L. J. Brady. 2005. Streptococcal viability
and diminished stress tolerance in mutants lacking the signal
recognition particle pathway or YidC2. Proc. Natl. Acad. Sci.
USA
102:17466-17471.[Abstract/Free Full Text]
72 - Hauck,
C. R., and K. Ohlsen. 2006. Sticky
connections: extracellular matrix protein recognition and
integrin-mediated cellular invasion by Staphylococcus aureus.Curr. Opin. Microbiol.
9:5-11.[CrossRef][Medline]
73 - Håvarstein,
L. S., D. B. Diep, and I. F. Nes.1995
. A family of bacteriocin ABC transporters carry out
proteolytic processing of their substrates concomitant with export.Mol. Microbiol.
16:229-240.[CrossRef][Medline]
74 - Heilmann,
C., M. Hussain, G. Peters, and F. Götz. 1997.
Evidence for autolysin-mediated primary attachment of Staphylococcus
epidermidis to a polystyrene surface. Mol. Microbiol.
24:1013-1024.[CrossRef][Medline]
75 - Herbort,
M., M. Klein, E. H. Manting, A. J. Driessen, and R.
Freudl. 1999. Temporal expression of the Bacillus
subtilis secA gene, encoding a central component of the preprotein
translocase. J. Bacteriol.
181:493-500.[Abstract/Free Full Text]
76 - Hiller,
K., A. Grote, M. Scheer, R. Münch, and D. Jahn.2004
. PrediSi: prediction of signal peptides and their
cleavage positions. Nucleic Acids Res.
32:W375-W379.[Abstract/Free Full Text]
77 - Hinsley,
A. P., N. R. Stanley, T. Palmer, and B.
C. Berks. 2001. A naturally occurring bacterial Tat
signal peptide lacking one of the invariant arginine
residues of the consensus targeting motif. FEBS Lett.
497:45-49.[CrossRef][Medline]
78 - Hiramatsu,
K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C.
Tenover. 1997. Methicillin-resistant
Staphylococcus aureus clinical strain with reduced vancomycin
susceptibility. J. Antimicrob. Chemother.
40:135-136.[Free Full Text]
79 - Holden,
M. T., E. J. Feil, J. A. Lindsay,
S. J. Peacock, N. P. Day, M. C. Enright,
T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, A.
Barron, N. Bason, S. D. Bentley, C. Chillingworth, T.
Chillingworth, C. Churcher, L. Clark, C. Corton, A. Cronin, J. Doggett,
L. Dowd, T. Feltwell, Z. Hance, B. Harris, H. Hauser, S. Holroyd, K.
Jagels, K. D. James, N. Lennard, A. Line, R. Mayes, S. Moule,
K. Mungall, D. Ormond, M. A. Quail, E. Rabbinowitsch, K.
Rutherford, M. Sanders, S. Sharp, M. Simmonds, K. Stevens,
S. Whitehead, B. G. Barrell, B. G. Spratt, and J.
Parkhill. 2004. Complete genomes of two clinical
Staphylococcus aureus strains: evidence for the rapid
evolution of virulence and drug resistance. Proc. Natl. Acad.
Sci. USA
101:9786-9791.[Abstract/Free Full Text]
80 - Holtfreter,
S., K. Bauer, D. Thomas, C. Feig, V. Lorenz, K. Roschack, E. Friebe, K.
Selleng, S. Lovenich, T. Greve, A. Greinacher, B. Panzig, S. Engelmann,
G. Lina, and B. M. Broker. 2004.
egc-encoded superantigens from Staphylococcus aureus
are neutralized by human sera much less efficiently than are classical
staphylococcal enterotoxins or toxic shock syndrome toxin.Infect. Immun.
72:4061-4071.[Abstract/Free Full Text]
81 - Huard,
C., G. Miranda, F. Wessner, A. Bolotin, J. Hansen, S. J.
Foster, and M. P. Chapot-Chartier.2003
. Characterization of AcmB, an
N-acetylglucosaminidase autolysin from
Lactococcus lactis. Microbiology
149:695-705.[Abstract/Free Full Text]
82 - Ignatova,
Z., C. Hornle, A. Nurk, and V. Kasche. 2002. Unusual
signal peptide directs penicillin amidase from Escherichia
coli to the Tat translocation machinery. Biochem. Biophys.
Res. Commun.
291:146-149.[CrossRef][Medline]
83 - Ilangovan,
U., H. Ton-That, J. Iwahara, O. Schneewind, and R. T.
Clubb. 2001. Structure of sortase, the transpeptidase
that anchors proteins to the cell wall of Staphylococcus
aureus. Proc. Natl. Acad. Sci. USA
98:6056-6061.[Abstract/Free Full Text]
84 - Ito,
T., X. X. Ma, F. Takeuchi, K. Okuma, H. Yuzawa, and K.
Hiramatsu. 2004. Novel type V staphylococcal cassette
chromosome mec driven by a novel cassette chromosome
recombinase, ccrC. Antimicrob. Agents
Chemother.
48:2637-2651.[Abstract/Free Full Text]
85 - Jevons,
M. P. 1961.
"Celbenin"-resistant staphylococci. BMJ
1:124-126.
86 - Ji,
Y., B. Zhang, S. F. Van Horn, P. Warren, G. Woodnutt,
M. K. Burnham, and M. Rosenberg. 2001.
Identification of critical staphylococcal genes using conditional
phenotypes generated by antisense RNA. Science
293:2266-2269.[Abstract/Free Full Text]
87 - Jongbloed,
J. D., H. Antelmann, M. Hecker, R. Nijland, S. Bron, U.
Airaksinen, F. Pries, W. J. Quax,
J. M. van Dijl, and P. G. Braun.2002
. Selective contribution of the twin-arginine
translocation pathway to protein secretion in Bacillus
subtilis. J. Biol. Chem.
277:44068-44078.[Abstract/Free Full Text]
88 - Jongbloed,
J. D., U. Grieger, H. Antelmann, M. Hecker, R. Nijland, S.
Bron, and J. M. van Dijl. 2004. Two minimal
Tat translocases in Bacillus. Mol. Microbiol.
54:1319-1325.[CrossRef][Medline]
89 - Jongbloed,
J. D., U. Martin, H. Antelmann, M. Hecker, H. Tjalsma, G.
Venema, S. Bron, J. M. van Dijl, and J. Müller.2000
. TatC is a specificity determinant for protein
secretion via the twin-arginine translocation pathway.J. Biol. Chem.
275:41350-41357.[Abstract/Free Full Text]
90 - Jongbloed,
J. D., R. van der Ploeg, and J. M. van Dijl.2005
. Bifunctional TatA subunits in minimal Tat protein
translocases. Trends Microbiol.
14:2-4.[CrossRef][Medline]
91 - Jonquieres,
R., H. Bierne, F. Fiedler, P. Gounon, and P. Cossart.1999
. Interaction between the protein InlB of
Listeria monocytogenes and lipoteichoicacid: a novel mechanism of protein association at the surface of
gram-positive bacteria. Mol. Microbiol.
34:902-914.[CrossRef][Medline]
92 - Joris,
B., S. Englebert, C. P. Chu, R. Kariyama, L. Daneo-Moore,
G. D. Shockman, and J. M. Ghuysen.1992
. Modular design of the Enterococcus hirae
muramidase-2 and Streptococcus faecalis autolysin. FEMS
Microbiol. Lett.
70:257-264.[Medline]
93 - Josefsson,
E., K. W. McCrea, D. Ni Eidhin, D. O'Connell, J. Cox, M.
Hook, and T. J. Foster. 1998. Three new
members of the serine-aspartate repeat protein multigene family of
Staphylococcus aureus. Microbiology
144:3387-3395.[Abstract]
94 - Juncker,
A. S., H. Willenbrock, G. von Heijne, S. Brunak, H. Nielsen,
and A. Krogh. 2003. Prediction of lipoprotein signal
peptides in gram-negative bacteria. Protein Sci.
12:1652-1662.[Abstract/Free Full Text]
95 - Kall,
L., A. Krogh, and E. L. Sonnhammer. 2004. A
combined transmembrane topology and signal peptide prediction method.J. Mol. Biol.
338:1027-1036.[CrossRef][Medline]
96 - Kanafani,
H., and S. E. Martin. 1985. Catalase and
superoxide dismutase activities in virulent and nonvirulent
Staphylococcus aureus isolates. J. Clin.
Microbiol.
21:607-610.[Abstract/Free Full Text]
97 - Kaneko,
J., and Y. Kamio. 2004. Bacterial two-component and
hetero-heptameric pore-forming cytolytic toxins: structures,
pore-forming mechanism, and organization of the genes. Biosci.
Biotechnol. Biochem.
68:981-1003.[CrossRef][Medline]
98 - Komatsuzawa,
H., K. Ohta, M. Sugai, T. Fujiwara, P. Glanzmann, B. Berger, and H.
Suginaka. 2000. Tn551-mediated insertional
inactivation of the fmtB gene encoding a cell wall-associated
protein abolishes methicillin resistance in Staphylococcus
aureus. J. Antimicrob. Chemother.
45:421-431.[Abstract/Free Full Text]
99 - Kontinen,
V. P., and M. Sarvas. 1993. The PrsA
lipoprotein is essential for protein secretion in Bacillus
subtilis and sets a limit for high-level secretion. Mol.
Microbiol.
8:727-737.[CrossRef][Medline]
100 - Kuroda,
M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A.
Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru,
A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K.
Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S.
Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K.
Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and
K. Hiramatsu. 2001. Whole genome sequencing of
methicillin-resistant Staphylococcus aureus.Lancet
357:1225-1240.[CrossRef][Medline]
101 - Leclercq,
R., E. Derlot, M. Weber, J. Duval, and P. Courvalin.1989
. Transferable vancomycin and teicoplanin resistance
in Enterococcus faecium. Antimicrob. Agents
Chemother.
33:10-15.[Abstract/Free Full Text]
102 - Lee,
L. Y., X. Liang, M. Hook, and E. L. Brown.2004
. Identification and characterization of the C3
binding domain of the Staphylococcus aureus extracellular
fibrinogen-binding protein (Efb). J. Biol.
Chem.
279:50710-50716.[Abstract/Free Full Text]
103 - Lee,
V. T., and O. Schneewind. 2001. Protein
secretion and the pathogenesis of bacterial infections. Genes
Dev.
15:1725-1752.[Free Full Text]
104 - Leskelä,
S., E. Wahlström, V. P. Kontinen, and M. Sarvas.1999
. Lipid modification of prelipoproteins is dispensable
for growth but essential for efficient protein secretion in
Bacillus subtilis: characterization of the lgt gene.Mol. Microbiol.
31:1075-1085.[CrossRef][Medline]
105 - Lory,
S. 1994. Leader peptidase of type IV prepilins and
related proteins, p. 17-29.
In G. von Heijne (ed.), Signal peptidases. R.
G. Landes Company, Austin,
Tex.
106 - Lory,
S. 1998. Secretion of proteins and assembly of
bacterial surface organelles: shared pathways of extracellular protein
targeting. Curr. Opin. Microbiol.
1:27-35.[CrossRef][Medline]
107 - Mack,
D., W. Fischer, A. Krokotsch, K. Leopold, R. Hartmann, H. Egge, and R.
Laufs. 1996. The intercellular adhesin involved in
biofilm accumulation of Staphylococcus epidermidis is a linear
beta-1,6-linked glucosaminoglycan: purification and structural
analysis. J. Bacteriol.
178:175-183.[Abstract/Free Full Text]
108 - Makris,
G., J. D. Wright, E. Ingham, and K. T. Holland.2004
. The hyaluronate lyase of Staphylococcus
aureusa virulence factor? Microbiology
150:2005-2013.[Abstract/Free Full Text]
109 - Mandell,
G. L. 1975. Catalase, superoxide dismutase,
and virulence of Staphylococcus aureus. In vitro and
in vivo studies with emphasis on staphylococcal-leukocyte
interaction. J. Clin. Investig.
55:561-566.[Medline]
110 - Margot,
P., and D. Karamata. 1996. The wprA gene of
Bacillus subtilis 168, expressed during exponential growth,
encodes a cell-wall-associated protease. Microbiology
142:3437-3444.[Abstract]
111 - Marraffini,
L. A., and O. Schneewind. 2005. Anchor
structure of staphylococcal surface proteins. V. Anchor structure of
the sortase B substrate IsdC. J. Biol. Chem.
280:16263-16271.[Abstract/Free Full Text]
112 - Marraffini,
L. A., H. Ton-That, Y. Zong, S. V. Narayana, and O.
Schneewind. 2004. Anchoring of surface proteins to the
cell wall of Staphylococcus aureus. A conserved arginine
residue is required for efficient catalysis of sortase A.J. Biol. Chem.
279:37763-37770.[Abstract/Free Full Text]
113 - Matsuyama,
S., Y. Fujita, and S. Mizushima. 1993. SecD is
involved in the release of translocated secretory proteins from the
cytoplasmic membrane of Escherichia coli. EMBO
J.
12:265-270.[Medline]
114 - Mazmanian,
S. K., E. P. Skaar, A. H. Gaspar, M.
Humayun, P. Gornicki, J. Jelenska, A. Joachmiak, D. M.
Missiakas, and O. Schneewind. 2003. Passage of
heme-iron across the envelope of Staphylococcus aureus.Science
299:906-909.[Abstract/Free Full Text]
115 - Mazmanian,
S. K., H. Ton-That, and O. Schneewind. 2001.
Sortase-catalysed anchoring of surface proteins to the cell
wall of Staphylococcus aureus. Mol. Microbiol.
40:1049-1057.[CrossRef][Medline]
116 - Mazmanian,
S. K., H. Ton-That, K. Su, and O. Schneewind.2002
. An iron-regulated sortase anchors a class of surface
protein during Staphylococcus aureus pathogenesis.Proc. Natl. Acad. Sci. USA
99:2293-2298.[Abstract/Free Full Text]
117 - McAuliffe,
O., R. P. Ross, and C. Hill. 2001.
Lantibiotics: structure, biosynthesis and mode of action. FEMS
Microbiol. Rev.
25:285-308.[CrossRef][Medline]
118 - Meima,
R., C. Eschevins, S. Fillinger, A. Bolhuis, L. W. Hamoen, R.
Dorenbos, W. J. Quax, J. M. van Dijl, R. Provvedi,
I. Chen, D. Dubnau, and S. Bron. 2002. The
bdbDC operon of Bacillus subtilis encodes
thiol-disulfide oxidoreductases required for competence development.J. Biol. Chem.
277:6994-7001.[Abstract/Free Full Text]
119 - Meima,
R., and J. M. van Dijl. 2003. Protein
secretion in gram-positive bacteria, p.271
-296. In B. Oudega (ed.),Protein secretion pathways in bacteria
. Kluwer Academic
Publishers, Dordrecht, The
Netherlands.
120 - Mempel,
M., C. Schnopp, M. Hojka, H. Fesq, S. Weidinger, M. Schaller,
H. C. Korting, J. Ring, and D. Abeck. 2002.
Invasion of human keratinocytes by Staphylococcus aureus and
intracellular bacterial persistence represent haemolysin-independent
virulence mechanisms that are followed by features of necrotic and
apoptotic keratinocyte cell death. Br. J.
Dermatol.
146:943-951.[CrossRef][Medline]
121 - Michiels,
J., G. Dirix, J. Vanderleyden, and C. Xi. 2001.
Processing and export of peptide pheromones and bacteriocins in
gram-negative bacteria. Trends Microbiol.
9:164-168.[CrossRef][Medline]
122 - Milward,
C. P., and N. A. Jacques. 1990.
Secretion of fructosyltransferase by Streptococcus salivarius
involves the sucrose-dependent release of the cell-bound form.J. Gen. Microbiol.
136:165-169.[Medline]
123 - Molik,
S., I. Karnauchov, C. Weidlich, R. G. Herrmann, and
R. B. Klösgen. 2001. The Rieske Fe/S
protein of the cytochrome b6/f complex in chloroplasts: missing link in
the evolution of protein transport pathways in chloroplasts?J. Biol. Chem.
276:42761-42766.[Abstract/Free Full Text]
124 - Morfeldt,
E., L. Janzon, S. Arvidson, and S. Löfdahl.1988
. Cloning of a chromosomal locus (exp) which
regulates the expression of several exoprotein genes in
Staphylococcus aureus. Mol. Gen. Genet.
211:435-440.[CrossRef][Medline]
125 - Mori,
H., and K. Cline. 2001. Post-translational protein
translocation into thylakoids by the Sec and DeltapH-dependent
pathways. Biochim. Biophys. Acta
1541:80-90.[CrossRef][Medline]
126 - Müller,
J. P., J. Ozegowski, S. Vettermann, J. Swaving, K.
H. Van Wely, and A. J. Driessen. 2000.
Interaction of Bacillus subtilis CsaA with SecA and precursor
proteins. Biochem. J.
348:367-373.[CrossRef][Medline]
127 - Nandakumar,
R., M. P. Nandakumar, M. R. Marten, and
J. M. Ross. 2005. Proteome analysis of
membrane and cell wall associated proteins from Staphylococcus
aureus. J. Proteome Res.
4:250-257.[CrossRef][Medline]
128 - Narita,
S., and H. Tokuda. 2006. An ABC transporter mediating
the membrane detachment of bacterial lipoproteins depending on their
sorting signals. FEBS Lett.
580:1164-1170.[CrossRef][Medline]
129 - Navaratna,
M. A., H. G. Sahl, and J. R. Tagg.1998
. Two-component anti-Staphylococcus aureus
lantibiotic activity produced by Staphylococcus aureus C55.Appl. Environ. Microbiol.
64:4803-4808.[Abstract/Free Full Text]
130 - Navaratna,
M. A., H. G. Sahl, and J. R. Tagg.1999
. Identification of genes encoding two-component
lantibiotic production in Staphylococcus aureus C55 and other
phage group II S. aureus strains and demonstration of an
association with the exfoliative toxin B gene. Infect.
Immun.
67:4268-4271.[Abstract/Free Full Text]
131 - Navarre,
W. W., and O. Schneewind. 1994. Proteolytic
cleavage and cell wall anchoring at the LPXTG motif of surface proteins
in gram-positive bacteria. Mol. Microbiol.
14:115-121.[CrossRef][Medline]
132 - Netz,
D. J., M. do Carmo de Freire Bastos, and H. G.
Sahl. 2002. Mode of action of the antimicrobial
peptide aureocin A53 from Staphylococcus aureus. Appl.
Environ. Microbiol.
68:5274-5280.[Abstract/Free Full Text]
133 - Netz,
D. J., R. Pohl, A. G. Beck-Sickinger, T. Selmer,
A. J. Pierik, M. do Carmo de Freire Bastos, and H.
G. Sahl. 2002. Biochemical characterisation and
genetic analysis of aureocin A53, a new, atypical
bacteriocin from Staphylococcus aureus.J. Mol. Biol.
319:745-756.[CrossRef][Medline]
134 - Netz,
D. J., H. G. Sahl, R. Marcelino, J. dos Santos
Nascimento, S. S. de Oliveira, M. B. Soares, and M.
do Carmo de Freire Bastos. 2001. Molecular
characterisation of aureocin A70, a multi-peptide bacteriocin isolated
from Staphylococcus aureus. J. Mol. Biol.
311:939-949.[CrossRef][Medline]
135 - Ní
Eidhin, D., S. Perkins, P. Francois, P. Vaudaux, M. Höök,
and T. J. Foster. 1998. Clumping factor B
(ClfB), a new surface-located fibrinogen-binding adhesin of
Staphylococcus aureus. Mol. Microbiol.
30:245-257.[CrossRef][Medline]
136 - Nielsen,
H., J. Engelbrecht, S. Brunak, and G. von Heijne.1997
. Identification of prokaryotic and eukaryotic signal
peptides and prediction of their cleavage sites. Protein
Eng.
10:1-6.[Abstract/Free Full Text]
137 - Noble,
W. C., Z. Virani, and R. G. Cree.1992
. Co-transfer of vancomycin and other resistance genes
from Enterococcus faecalis NCTC 12201 to Staphylococcus
aureus. FEMS Microbiol. Lett.
72:195-198.[CrossRef][Medline]
138 - Nouwen,
N., M. Piwowarek, G. Berrelkamp, and A. J. Driessen.2005
. The large first periplasmic loop of SecD and SecF
plays an important role in SecDF functioning. J.
Bacteriol.
187:5857-5860.[Abstract/Free Full Text]
139 - Oshida,
T., M. Sugai, H. Komatsuzawa, Y. M. Hong, H. Suginaka, and A.
Tomasz. 1995. A Staphylococcus aureus
autolysin that has an
N-acetylmuramoyl-L-alanine amidase domain
and an endo-beta-N-acetylglucosaminidase domain: cloning,
sequence analysis, and characterization. Proc. Natl. Acad. Sci.
USA
92:285-289.[Abstract/Free Full Text]
140 - Pallen,
M. J. 2002. The ESAT-6/WXG100
superfamilyand a new gram-positive secretion system?Trends Microbiol.
10:209-212.[CrossRef][Medline]
141 - Palmqvist,
N., J. M. Patti, A. Tarkowski, and E. Josefsson.2004
. Expression of staphylococcal clumping factor A
impedes macrophage phagocytosis. Microbes Infect.
6:188-195.[CrossRef][Medline]
142 - Palmqvist,
N., G. J. Silverman, E. Josefsson, and A. Tarkowski.2005
. Bacterial cell wall-expressed protein A triggers
supraclonal B-cell responses upon in vivo infection with
Staphylococcus aureus. Microbes Infect.
7:1501-1511.[CrossRef][Medline]
143 - Peacock,
S. J., I. de Silva, and F. D. Lowy.2001
. What determines nasal carriage of Staphylococcus
aureus? Trends Microbiol.
9:605-610.[CrossRef][Medline]
144 - Peng,
H. L., R. P. Novick, B. Kreiswirth, J. Kornblum,
and P. Schlievert. 1988. Cloning, characterization,
and sequencing of an accessory gene regulator (agr) in
Staphylococcus aureus. J. Bacteriol.
170:4365-4372.[Abstract/Free Full Text]
145 - Peschel,
A., N. Schnell, M. Hille, K. D. Entian, and F. Gotz.1997
. Secretion of the lantibiotics epidermin and
gallidermin: sequence analysis of the genes gdmT and gdmH, their
influence on epidermin production and their regulation by EpiQ.Mol. Gen. Genet.
254:312-318.[CrossRef][Medline]
146 - Ponting,
C. P., L. Aravind, J. Schultz, P. Bork, and E. V.
Koonin. 1999. Eukaryotic signalling domain homologues
in archaea and bacteria. Ancient ancestry and horizontal gene transfer.J. Mol. Biol.
289:729-745.[CrossRef][Medline]
147 - Prágai,
Z., H. Tjalsma, A. Bolhuis, J. M. van Dijl, G. Venema, and S.
Bron. 1997. The signal peptidase II (Isp)
gene of Bacillus subtilis. Microbiology
143:1327-1333.[Abstract]
148 - Pugsley,
A. P. 1993. Processing and methylation of
PuIG, a pilin-like component of the general secretory pathway of
Klebsiella oxytoca. Mol. Microbiol.
9:295-308.[CrossRef][Medline]
149 - Que,
Y. A., J. A. Haefliger, L. Piroth, P. Francois, E.
Widmer, J. M. Entenza, B. Sinha, M. Herrmann, P. Francioli,
P. Vaudaux, and P. Moreillon. 2005. Fibrinogen and
fibronectin binding cooperate for valve infection and invasion in
Staphylococcus aureus experimental endocarditis. J.
Exp. Med.
201:1627-1635.[Abstract/Free Full Text]
150 - Rashid,
M. H., M. Mori, and J. Sekiguchi. 1995.
Glucosaminidase of Bacillus subtilis:
cloning, regulation, primary structure and biochemical
characterization. Microbiology
141:2391-2404.[Abstract]
151 - Rathsam,
C., P. M. Giffard, and N. A. Jacques.1993
. The cell-bound fructosyltransferase of
Streptococcus salivarius: the carboxyl terminus specifies
attachment in a Streptococcus gordonii model system. J.
Bacteriol.
175:4520-4527.[Abstract/Free Full Text]
152 - Recsei,
P., B. Kreiswirth, M. O'Reilly, P. Schlievert, A. Gruss, and
R. P. Novick. 1986. Regulation of exoprotein
gene expression in Staphylococcus aureus by agar. Mol.
Gen. Genet.
202:58-61.[CrossRef][Medline]
153 - Rice,
K. C., B. A. Firek, J. B. Nelson,
S. J. Yang, T. G. Patton, and K. W.
Bayles. 2003. The Staphylococcus aureus cidAB
operon: evaluation of its role in regulation of murein hydrolase
activity and penicillin tolerance. J. Bacteriol.
185:2635-2643.[Abstract/Free Full Text]
154 - Robinson,
C., and A. Bolhuis. 2001. Protein targeting by the
twin-arginine translocation pathway. Nat. Rev. Mol. Cell
Biol.
2:350-356.[CrossRef][Medline]
155 - Roche,
F. M., R. Downer, F. Keane, P. Speziale, P. W.
Park, and T. J. Foster. 2004. The N-terminal
A domain of fibronectin-binding proteins A and B promotes adhesion of
Staphylococcus aureus to elastin. J. Biol.
Chem.
279:38433-38440.[Abstract/Free Full Text]
156 - Roche,
F. M., R. Massey, S. J. Peacock, N. P.
Day, L. Visai, P. Speziale, A. Lam, M. Pallen, and T. J.
Foster. 2003. Characterization of novel
LPXTG-containing proteins of Staphylococcus aureus identified
from genome sequences. Microbiology
149:643-654.[Abstract/Free Full Text]
157 - Rohde,
H., C. Burdelski, K. Bartscht, M. Hussain, F. Buck, M. A.
Horstkotte, J. K. Knobloch, C. Heilmann, M. Herrmann, and D.
Mack. 2005. Induction of Staphylococcus
epidermidis biofilm formation via proteolytic processing of the
accumulation-associated protein by staphylococcal and host proteases.Mol. Microbiol.
55:1883-1895.[CrossRef][Medline]
158 - Ruzin,
A., and R. P. Novick. 2000. Equivalence of
lauric acid and glycerol monolaurate as inhibitors of signal
transduction in Staphylococcus aureus. J.
Bacteriol.
182:2668-2671.[Abstract/Free Full Text]
159 - Sander,
P., M. Rezwan, B. Walker, S. K. Rampini, R. M.
Kroppenstedt, S. Ehlers, C. Keller, J. R. Keeble, M.
Hagemeier, M. J. Colston, B. Springer, and E. C.
Böttger. 2004. Lipoprotein processing is
required for virulence of Mycobacterium tuberculosis.Mol. Microbiol.
52:1543-1552.[CrossRef][Medline]
160 - Sankaran,
K., K. Gan, B. Rash, H. Y. Qi, H. C. Wu, and
P. D. Rick. 1997. Roles of histidine-103 and
tyrosine-235 in the function of the prolipoprotein diacylglyceryl
transferase of Escherichia coli. J. Bacteriol.
179:2944-2948.[Abstract/Free Full Text]
161 - Sankaran,
K., and H. C. Wu. 1994. Lipid modification
of bacterial prolipoprotein. Transfer of diacylglyceryl moiety
from phosphatidylglycerol. J. Biol. Chem.
269:19701-19706.[Abstract/Free Full Text]
162 - Sarvas,
M., C. R. Harwood, S. Bron, and J. M. van Dijl.2004
. Post-translocational folding of secretory proteins
in gram-positive bacteria. Biochim. Biophys. Acta
1694:311-327.[Medline]
163 - Savolainen,
K., L. Paulin, B. Westerlund-Wikström, T. J. Foster,
T. K. Korhonen, and P. Kuusela. 2001.
Expression of pls, a gene closely associated with the
mecA gene of methicillin-resistant Staphylococcus
aureus, prevents bacterial adhesion in vitro. Infect.
Immun.
69:3013-3020.[Abstract/Free Full Text]
164 - Schnell,
N., K. D. Entian, U. Schneider, F. Götz, H.
Zähner, R. Kellner, and G. Jung. 1988.
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic
with four sulphide-rings. Nature
333:276-278.[CrossRef][Medline]
165 - Siboo,
I. R., H. F. Chambers, and P. M.
Sullam. 2005. Role of SraP, a serine-rich surface
protein of Staphylococcus aureus, in binding to human
platelets. Infect. Immun.
73:2273-2280.[Abstract/Free Full Text]
166 - Sørensen,
A. L., S. Nagai, G. Houen, P. Andersen, and A. B.
Andersen. 1995. Purification and characterization of a
low-molecular-mass T-cell antigen secreted by Mycobacterium
tuberculosis. Infect. Immun.
63:1710-1717.[Abstract]
167 - Stanley,
N. R., T. Palmer, and B. C. Berks.2000
. The twin arginine consensus motif of Tat signal
peptides is involved in Sec-independent protein targeting in
Escherichia coli. J. Biol. Chem.
275:11591-11596.[Abstract/Free Full Text]
168 - Steen,
A. 2005. Functional characterization and cell wall
interactions of peptidoglycan hydrolases of Lactococcus
lactis. University of Groningen, Groningen, The
Netherlands.
169 - Stoll,
H., J. Dengjel, C. Nerz, and F. Götz. 2005.
Staphylococcus aureus deficient in lipidation of
prelipoproteins is attenuated in growth and immune activation.Infect. Immun.
73:2411-2423.[Abstract/Free Full Text]
170 - Strom,
M. S., D. N. Nunn, and S. Lory.1993
. A single bifunctional enzyme, PilD, catalyzes
cleavage and N-methylation of proteins belonging to the type IV pilin
family. Proc. Natl. Acad. Sci. USA
90:2404-2408.[Abstract/Free Full Text]
171 - Sutcliffe,
I. C., and D. J. Harrington. 2002.
Pattern searches for the identification of putative lipoprotein genes
in gram-positive bacterial genomes. Microbiology
148:2065-2077.[Abstract/Free Full Text]
172 - Takamatsu,
D., B. A. Bensing, and P. M. Sullam.2005
. Two additional components of the accessory
sec system mediating export of the Streptococcus
gordonii platelet-binding protein GspB. J.
Bacteriol.
187:3878-3883.[Abstract/Free Full Text]
173 - Tarkowski,
A., L. V. Collins, I. Gjertsson, O. H. Hultgren,
I. M. Jonsson, E. Sakiniene, and M. Verdrengh.2001
. Model systems: modeling human staphylococcal
arthritis and sepsis in the mouse. Trends Microbiol.
9:321-326.[CrossRef][Medline]
174 - Tjalsma,
H., H. Antelmann, J. D. Jongbloed, P. G. Braun, E.
Darmon, R. Dorenbos, J. Y. Dubois, H. Westers, G. Zanen,
W. J. Quax, O. P. Kuipers, S. Bron, M. Hecker, and
J. M. van Dijl. 2004. Proteomics of protein
secretion by Bacillus subtilis: separating the
"secrets" of the secretome. Microbiol. Mol.
Biol. Rev.
68:207-233.[Abstract/Free Full Text]
175 - Tjalsma,
H., A. Bolhuis, J. D. Jongbloed, S. Bron, and J. M.
van Dijl. 2000. Signal peptide-dependent protein
transport in Bacillus subtilis: a genome-based survey of the
secretome. Microbiol. Mol. Biol. Rev.
64:515-547.[Abstract/Free Full Text]
176 - Tjalsma,
H., A. Bolhuis, M. L. van Roosmalen, T. Wiegert, W. Schumann,
C. P. Broekhuizen, W. J. Quax, G. Venema, S. Bron,
and J. M. van Dijl. 1998. Functional
analysis of the secretory precursor processing machinery of
Bacillus subtilis: identification of a eubacterial homolog of
archaeal and eukaryotic signal peptidases. Genes Dev.
12:2318-2331.[Abstract/Free Full Text]
177 - Tjalsma,
H., V. P. Kontinen, Z. Prágai, H. Wu, R. Meima, G.
Venema, S. Bron, M. Sarvas, and J. M. van Dijl.1999
. The role of lipoprotein processing by signal
peptidase II in the gram-positive eubacterium Bacillus
subtilis. Signal peptidase II is required for the efficient
secretion of alpha-amylase, a non-lipoprotein. J.
Biol. Chem.
274:1698-1707.[Abstract/Free Full Text]
178 - Tjalsma,
H., M. A. Noback, S. Bron, G. Venema, K. Yamane, and
J. M. van Dijl. 1997. Bacillus
subtilis contains four closely related type I signal peptidases
with overlapping substrate specificities. Constitutive and temporally
controlled expression of different sip genes.J. Biol. Chem.
272:25983-25992.[Abstract/Free Full Text]
179 - Tjalsma,
H., and J. M. van Dijl. 2005.
Proteomics-based consensus prediction of protein retention in a
bacterial membrane. Proteomics
5:4472-4482.[CrossRef][Medline]
180 - Tjalsma,
H., G. Zanen, S. Bron, and J. M. van Dijl.2001
. The eubacterial lipoprotein-specific (type II)
signal peptidase, p. 3-23. In
R. E. Dalbey and D. S. Sigman (ed.), The
enzymes, vol. XXII. Co- and post translational proteolysis of
proteins. Academic Press, San Diego,
Calif.
181 - Tokuda,
H., and S. Matsuyama. 2004. Sorting of lipoproteins to
the outer membrane in E. coli. Biochim. Biophys.
Acta
1694:IN1-IN9.[Medline]
182 - Ton-That, H., L. A. Marraffini, and O. Schneewind.2004
. Protein sorting to the cell wall envelope of gram-positive bacteria. Biochim. Biophys. Acta
1694:269-278.[CrossRef][Medline]
183 - Ton-That,
H., S. K. Mazmanian, L. Alksne, and O. Schneewind.2002
. Anchoring of surface proteins to the cell wall of
Staphylococcus aureus. Cysteine 184 and histidine 120 of
sortase form a thiolate-imidazolium ion pair for catalysis.J. Biol. Chem.
277:7447-7452.[Abstract/Free Full Text]
184 - Tormo,
M. A., E. Knecht, F. Götz, I. Lasa, and J. R.
Penadés. 2005. Bap-dependent biofilm formation
by pathogenic species of Staphylococcus: evidence of
horizontal gene transfer? Microbiology
151:2465-2475.[Abstract/Free Full Text]
185 - Vandenesch,
F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo,
H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. E.
Reverdy, and J. Etienne. 2003. Community-acquired
methicillin-resistant Staphylococcus aureus carrying
Panton-Valentine leukocidin genes: worldwide emergence. Emerg.
Infect. Dis.
9:978-984.[Medline]
186 - van
Dijl, J. M., A. de Jong, J. Vehmaanperä, G. Venema, and
S. Bron. 1992. Signal peptidase I of Bacillus
subtilis: patterns of conserved amino acids in prokaryotic and
eukaryotic type I signal peptidases. EMBO J.
11:2819-2828.[Medline]
187 - van
Roosmalen, M. L., N. Geukens, J. D. Jongbloed, H.
Tjalsma, J. Y. Dubois, S. Bron, J. M. van Dijl, and
J. Anné. 2004. Type I signal peptidases of
gram-positive bacteria. Biochim. Biophys. Acta
1694:279-297.[CrossRef][Medline]
188 - van
Roosmalen, M. L., J. D. Jongbloed, J. Y.
Dubois, G. Venema, S. Bron, and J. M. van Dijl.2001
. Distinction between major and minor
Bacillus signal peptidases based on phylogenetic and
structural criteria. J. Biol. Chem.
276:25230-25235.[Abstract/Free Full Text]
189 - Veenendaal,
A. K., C. van der Does, and A. J. Driessen.2004
. The protein-conducting channel SecYEG.Biochim. Biophys. Acta
1694:81-95.[CrossRef][Medline]
190 - Venema,
R., H. Tjalsma, J. M. van Dijl, A. de Jong, K. Leenhouts, G.
Buist, and G. Venema. 2003. Active lipoprotein
precursors in the gram-positive eubacterium Lactococcus
lactis. J. Biol. Chem.
278:14739-14746.[Abstract/Free Full Text]
191 - Viau,
M., N. S. Longo, P. E. Lipsky, and M. Zouali.2005
. Staphylococcal protein A deletes B-1a and marginal
zone B lymphocytes expressing human immunoglobulins: an immune evasion
mechanism. J. Immunol.
175:7719-7727.[Abstract/Free Full Text]
192 - Vitikainen,
M., I. Lappalainen, R. Seppala, H. Antelmann, H. Boer, S. Taira, H.
Savilahti, M. Hecker, M. Vihinen, M. Sarvas, and V. P.
Kontinen. 2004. Structure-function analysis of PrsA
reveals roles for the parvulin-like and flanking N- and C-terminal
domains in protein folding and secretion in Bacillus subtilis.J. Biol. Chem.
279:19302-19314.[Abstract/Free Full Text]
193 - Voigt,
B., T. Schweder, M. J. Sibbald, D. Albrecht, A. Ehrenreich,
J. Bernhardt, J. Feesche, K. H. Maurer,
G. Gottschalk, J. M. van Dijl, and M. Hecker.2006
. The extracellular proteome of Bacillus
licheniformis grown in different media and under different
nutrient starvation conditions. Proteomics
6:268-281.[CrossRef][Medline]
194 - Völker,
U., and M. Hecker. 2005. From genomics via proteomics
to cellular physiology of the gram-positive model organism Bacillus
subtilis. Cell. Microbiol.
7:1077-1085.[CrossRef][Medline]
195 - von
Heijne, G. 1990. The signal peptide. J. Membr.
Biol.
115:195-201.[CrossRef][Medline]
196 - Voyich,
J. M., K. R. Braughton, D. E. Sturdevant,
A. R. Whitney, B. Said-Salim, S. F. Porcella,
R. D. Long, D. W. Dorward, D. J. Gardner,
B. N. Kreiswirth, J. M. Musser, and F. R.
DeLeo. 2005. Insights into mechanisms used by
Staphylococcus aureus to avoid destruction by human
neutrophils. J. Immunol.
175:3907-3919.[Abstract/Free Full Text]
197 - Vrontou,
E., and A. Economou. 2004. Structure and function of
SecA, the preprotein translocase nanomotor. Biochim. Biophys.
Acta
1694:67-80.[CrossRef][Medline]
198 - Walsh,
E. J., L. M. O'Brien, X. Liang, M. Hook, and
T. J. Foster. 2004. Clumping factor B, a
fibrinogen-binding MSCRAMM (microbial surface components recognizing
adhesive matrix molecules) adhesin of Staphylococcus aureus,
also binds to the tail region of type I cytokeratin 10.J. Biol. Chem.
279:50691-50699.[Abstract/Free Full Text]
199 - Weigel,
L. M., D. B. Clewell, S. R. Gill,
N. C. Clark, L. K. McDougal, S. E.
Flannagan, J. F. Kolonay, J. Shetty, G. E.
Killgore, and F. C. Tenover. 2003. Genetic
analysis of a high-level vancomycin-resistant isolate of
Staphylococcus aureus. Science
302:1569-1571.[Abstract/Free Full Text]
200 - Westers,
H., R. Dorenbos, J. M. van Dijl, J. Kabel, T. Flanagan,
K. M. Devine, F. Jude, S. J. Seror, A. C.
Beekman, E. Darmon, C. Eschevins, A. de Jong, S. Bron, O. P.
Kuipers, A. M. Albertini, H. Antelmann, M. Hecker, N.
Zamboni, U. Sauer, C. Bruand, D. S. Ehrlich, J. C.
Alonso, M. Salas, and W. J. Quax. 2003.
Genome engineering reveals large dispensable regions in Bacillus
subtilis. Mol. Biol. Evol.
20:2076-2090.[Abstract/Free Full Text]
201 - Wickner,
W., and R. Schekman. 2005. Protein translocation
across biological membranes. Science
310:1452-1456.[Abstract/Free Full Text]
202 - Wu,
H. C. 1996. Biosynthesis of lipoproteins, p.1005
-1014. In F.
C. Neidhardt, R. Curtis III, J. L.
Ingraham, K. B. Low, B. Magasanik, W. S. Reznikoff,
M. Riley, M. Schaechter, and H. E. Umbarger (ed.),Escherichia coli and Salmonella: cellular and
molecular biology
. American Society for Microbiology,
Washington,
D.C.
203 - Yamasaki,
O., T. Yamaguchi, M. Sugai, C. Chapuis-Cellier, F. Arnaud, F.
Vandenesch, J. Etienne, and G. Lina. 2005. Clinical
manifestations of staphylococcal scalded-skin syndrome depend on
serotypes of exfoliative toxins. J. Clin.
Microbiol.
43:1890-1893.[Abstract/Free Full Text]
204 - Yen,
M. R., Y. H. Tseng, E. H. Nguyen,
L. F. Wu, and M. H. Saier, Jr.2002
. Sequence and phylogenetic analyses of the
twin-arginine targeting (Tat) protein export system. Arch.
Microbiol.
177:441-450.[CrossRef][Medline]
205 - Yother,
J., and J. M. White. 1994. Novel surface
attachment mechanism of the Streptococcus pneumoniae protein
PspA. J. Bacteriol.
176:2976-2985.[Abstract/Free Full Text]
206 - Young,
R., and U. Bläsi. 1995. Holins: form and
function in bacteriophage lysis. FEMS Microbiol. Rev.
17:191-205.[CrossRef][Medline]
207 - Zhang,
Y. Q., S. X. Ren, H. L. Li, Y.
X. Wang, G. Fu, J. Yang, Z. Q. Qin, Y. G. Miao,
W. Y. Wang, R. S. Chen, Y. Shen, Z. Chen,
Z. H. Yuan, G. P. Zhao, D. Qu, A. Danchin, and
Y. M. Wen. 2003. Genome-based analysis of
virulence genes in a non-biofilm-forming Staphylococcus
epidermidis strain (ATCC 12228). Mol. Microbiol.
49:1577-1593.[CrossRef][Medline]
208 - Ziebandt,
A. K., D. Becher, K. Ohlsen, J. Hacker, M. Hecker, and S.
Engelmann. 2004. The influence of agr and
sigma(B) in growth phase dependent regulation of virulence factors in
Staphylococcus aureus. Proteomics
4:3034-3047.[CrossRef][Medline]
209 - Ziebandt,
A. K., H. Weber, J. Rudolph, R. Schmid, D. Höper, S.
Engelmann, and M. Hecker. 2001. Extracellular proteins
of Staphylococcus aureus and the role of SarA and sigma B.Proteomics
1:480-493.[CrossRef][Medline]
Microbiology and Molecular Biology Reviews, September 2006, p. 755-788, Vol. 70, No. 3
1092-2172/06/$08.00+0 doi:10.1128/MMBR.00008-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Prat, C., Haas, P.-J., Bestebroer, J., de Haas, C. J. C., van Strijp, J. A. G., van Kessel, K. P. M.
(2009). A Homolog of Formyl Peptide Receptor-Like 1 (FPRL1) Inhibitor from Staphylococcus aureus (FPRL1 Inhibitory Protein) That Inhibits FPRL1 and FPR. J. Immunol.
183: 6569-6578
[Abstract]
[Full Text]
-
Biswas, L., Biswas, R., Nerz, C., Ohlsen, K., Schlag, M., Schafer, T., Lamkemeyer, T., Ziebandt, A.-K., Hantke, K., Rosenstein, R., Gotz, F.
(2009). Role of the Twin-Arginine Translocation Pathway in Staphylococcus. J. Bacteriol.
191: 5921-5929
[Abstract]
[Full Text]
-
Smyth, D. S., Robinson, D. A.
(2009). Integrative and Sequence Characteristics of a Novel Genetic Element, ICE6013, in Staphylococcus aureus. J. Bacteriol.
191: 5964-5975
[Abstract]
[Full Text]
-
Schmaler, M., Jann, N. J., Ferracin, F., Landolt, L. Z., Biswas, L., Gotz, F., Landmann, R.
(2009). Lipoproteins in Staphylococcus aureus Mediate Inflammation by TLR2 and Iron-Dependent Growth In Vivo. J. Immunol.
182: 7110-7118
[Abstract]
[Full Text]
-
Denham, E. L., Ward, P. N., Leigh, J. A.
(2009). In the absence of Lgt, lipoproteins are shed from Streptococcus uberis independently of Lsp. Microbiology
155: 134-141
[Abstract]
[Full Text]
-
Kouwen, T. R. H. M., Dubois, J.-Y. F., Freudl, R., Quax, W. J., van Dijl, J. M.
(2008). Modulation of Thiol-Disulfide Oxidoreductases for Increased Production of Disulfide-Bond-Containing Proteins in Bacillus subtilis. Appl. Environ. Microbiol.
74: 7536-7545
[Abstract]
[Full Text]
-
Tsuru, T., Kobayashi, I.
(2008). Multiple Genome Comparison within a Bacterial Species Reveals a Unit of Evolution Spanning Two Adjacent Genes in a Tandem Paralog Cluster. Mol Biol Evol
25: 2457-2473
[Abstract]
[Full Text]
-
Ben Zakour, N. L., Sturdevant, D. E., Even, S., Guinane, C. M., Barbey, C., Alves, P. D., Cochet, M.-F., Gautier, M., Otto, M., Fitzgerald, J. R., Le Loir, Y.
(2008). Genome-Wide Analysis of Ruminant Staphylococcus aureus Reveals Diversification of the Core Genome. J. Bacteriol.
190: 6302-6317
[Abstract]
[Full Text]
-
Maresso, A. W., Schneewind, O.
(2008). Sortase as a Target of Anti-Infective Therapy. Pharmacol. Rev.
60: 128-141
[Abstract]
[Full Text]
-
Boisset, S., Geissmann, T., Huntzinger, E., Fechter, P., Bendridi, N., Possedko, M., Chevalier, C., Helfer, A. C., Benito, Y., Jacquier, A., Gaspin, C., Vandenesch, F., Romby, P.
(2007). Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev.
21: 1353-1366
[Abstract]
[Full Text]